<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02865538</url>
  </required_header>
  <id_info>
    <org_study_id>21681</org_study_id>
    <nct_id>NCT02865538</nct_id>
  </id_info>
  <brief_title>Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms</brief_title>
  <acronym>RELENT-1</acronym>
  <official_title>Evaluation of the Pharmacokinetics and Safety of NT-814 in Post-Menopausal Women With Vasomotor Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nerre Therapeutics Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, double-blind, randomized, placebo-controlled multiple ascending dose&#xD;
      study in post-menopausal women with vasomotor symptoms. Single ascending doses of NT-814 will&#xD;
      be investigated in 4 cohorts. Each cohort will comprise of 20 subjects. Subjects will be&#xD;
      dosed for 14 days.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Actual">March 28, 2017</completion_date>
  <primary_completion_date type="Actual">March 28, 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum Observed Plasma Concentration (Cmax) of BAY3427080</measure>
    <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
    <description>Cmax is the maximum observed plasma concentration of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Reach Maximum Observed Drug Concentration in Plasma (Tmax) of BAY3427080</measure>
    <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
    <description>Time of occurrence of Cmax.Time to reach maximum plasma concentration of BAY3427080 was presented. Blood samples for Tmax were taken within 30 minutes prior to dose administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinity (AUC0-∞) of BAY3427080</measure>
    <time_frame>Day 1 (pre-dose and post-dose (0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 8.0, 12.0 and 24.0 hours)</time_frame>
    <description>AUC from time zero extrapolated to infinity of BAY3427080 was presented. AUC0-∞ was only estimated following the Day 1 dose.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Area Under the Concentration-time Curve (AUC) From Time Zero to the Time of the Last Quantifiable Concentration (AUC0-τ) of BAY3427080</measure>
    <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
    <description>Area under the concentration-time curve (AUC) from time zero to the time of the last quantifiable concentration of BAY3427080 was presented. Blood samples for (AUC0-τ) were taken within 30 minutes prior to dose administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Terminal Elimination Half-life (t½) of BAY3427080</measure>
    <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
    <description>Terminal elimination half-life of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Apparent Clearance (CL/F) of BAY3427080</measure>
    <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
    <description>Apparent clearance of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Significant Abnormalities Detected Upon Physical Examination.</measure>
    <time_frame>At day 14</time_frame>
    <description>A physician or appropriately qualified delegate conducted a full physical examination. Clinically significance was decided by investigator. The findings are presented as abnormal (clinically significant).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Clinically Significant Abnormalities on the 12-lead ECGs</measure>
    <time_frame>At day 14</time_frame>
    <description>Reported results are cardiovascular system-examination findings at day 14. Clinically significance was decided by investigator. The findings are presented as abnormal (clinically significant).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Arrhythmias as Assessed by Continuous Holter Monitoring.</measure>
    <time_frame>Baseline (day -1) and day 14</time_frame>
    <description>Holter monitors were supplied by iCardiac Technologies. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14 and remained in place until 24-hour assessments were completed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Diastolic Blood Pressure (Standing)</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Diastolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in standing position.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Diastolic Blood Pressure (Sitting)</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Diastolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in sitting position.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Systolic Blood Pressure (Standing)</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Systolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in standing position.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Systolic Blood Pressure (Sitting)</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Systolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in sitting position.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Pulse Rate</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Pulse rate was measured just prior to dosing (approx. 30 mins).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Respiratory Rate</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Respiratory rate was measured just prior to dosing (approx. 30 mins).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Oxygen Saturation</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Oxygen Saturation was measured just prior to dosing (approx. 30 mins).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Oral Body Temperature</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Temperature was measured just prior to dosing (approx. 30 mins).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 in Vital Signs: Weight</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Weight was measured just prior to dosing (approx. 30 mins).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 15 for Laboratory Hormones Results : Adrenocorticotropic Hormone (ADTH) and Estradiol.</measure>
    <time_frame>Baseline and day 15</time_frame>
    <description>Blood samples for the assessment of ACTH and Estradiol were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 15 for Laboratory Hormones Results: Follicle Stimulating Hormone</measure>
    <time_frame>Baseline and day 15</time_frame>
    <description>Blood samples for the assessment of Follicle Stimulating were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 15 for Laboratory Hormones Results : Triiodothyronine Uptake</measure>
    <time_frame>Baseline and day 15</time_frame>
    <description>Blood samples for the assessment of Triiodothyronine were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 15 for Laboratory Hormones Results: Thyrotropin</measure>
    <time_frame>Baseline and day 15</time_frame>
    <description>Blood samples for the assessment of Thyrotropin were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 15 for Laboratory Hormones Results : Cortisol, Testosterone, Thyroxine and Triiodothyronine</measure>
    <time_frame>Baseline and day 15</time_frame>
    <description>Blood samples for the assessment of Cortisol, Testosterone, Thyroxine and Triiodothyronine were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Clinical Laboratory Parameters LIPIDS : Cholesterol, Triglycerides, HDL Cholesterol and LDL Cholesterol.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Cholesterol, Triglycerides,high-density lipoprotein (HDL)Cholesterol and low-density lipoprotein (LDL) Cholesterol were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils and Immature Granulocytes.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Neutrophils/Leukocytes, Lymphocytes /Leukocytes, Monocytes/Leukocytes, Eosinophils/Leukocytes, Basophils/Leukocytes and Immature Granulocytes/ Leukocytes were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Clinical Laboratory Parameters HEMATOLOGY: Leukocytes, Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils, Immature Granulocytes and Platelets.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Leukocytes, Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils, Immature Granulocytes and Platelets were collected upon participant's admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Hemoglobin and Erythrocytes Mean Corpuscular Hemoglobin Concentration</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Hemoglobin and Erythrocytes Mean Corpuscular Hemoglobin (HB)concentration were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Erythrocytes were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Mean Corpuscular Volume and Mean Platelet Volume.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Erythrocytes Mean Corpuscular Volume and Mean Platelet Volume were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Mean Corpuscular Hemoglobin</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Erythrocytes Mean Corpuscular Hemoglobin were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Distribution Width.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Erythrocytes Distribution Width were collected upon participants admission to the unit. Erythrocytes distribution width (in percentage) = 1 SD of Erythrocyte volume/MCV x 100%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Hematocrit.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Hematocrit were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Protein and Albumin.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Protein and Albumin were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Alkaline Phosphatase, Alanine Aminotransferase, Aspartate Aminotransferase, Gamma Glutamyl Transferase and Creatine Kinase</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Alkaline Phosphatase, Alanine Aminotransferase, Aspartate Aminotransferase, Gamma Glutamyl Transferase and Creatine Kinase were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Urate, Bilirubin and Creatinine.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Urate, Bilirubin and Creatinine were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for Clinical Laboratory Parameters CHEMISTRY: Sodium, Potassium, Chloride, Bicarbonate, Calcium, Phosphate, Glucose, Magnesium and Urea Nitrogen.</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Sodium, Potassium, Chloride, Bicarbonate, Calcium, Phosphate, Glucose, Magnesium and Urea Nitrogen were collected upon participant's admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laboratory Parameters CHEMISTRY: Glomerular Filtration Rate African at Baseline</measure>
    <time_frame>At Baseline</time_frame>
    <description>Blood samples for the assessment of Glomerular Filtration Rate African were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Laboratory Parameters CHEMISTRY: Glomerular Filtration Rate Caucasian at Baseline</measure>
    <time_frame>At Baseline</time_frame>
    <description>Blood samples for the assessment of Glomerular Filtration Rate Caucasian were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for COAGULATION: Prothrombin International Normalized Ratio (INR)</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Prothrombin International Normalized Ratio were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline at Day 14 for COAGULATION: Prothrombin Time and Activated Partial Thromboplastin Time</measure>
    <time_frame>Baseline and day 14</time_frame>
    <description>Blood samples for the assessment of Prothrombin Time and Activated Partial Thromboplastin Time were collected upon participants admission to the unit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart Rate (HR) - Change From Baseline (Day -1) at Day 14</measure>
    <time_frame>Baseline (day -1) and day 14</time_frame>
    <description>Heart rate was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made.Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean PR Interval - Change From Baseline (Day -1) at Day 14</measure>
    <time_frame>Baseline (day -1) and day 14</time_frame>
    <description>PR Interval was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean QRS Duration - Change From Baseline (Day -1) at Day 14</measure>
    <time_frame>Baseline (day -1) and day 14</time_frame>
    <description>QRS Duration was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean QT Interval - Change From Baseline (Day -1) at Day 14</measure>
    <time_frame>Baseline (day -1) and day 14</time_frame>
    <description>QT Interval was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean QTcF Interval (Fridericia's Correction Formula, QTcF) - Change From Baseline (Day -1) at Day 14</measure>
    <time_frame>Baseline (day -1) and day 14</time_frame>
    <description>Fridericia-corrected QTcF interval was evaluated as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean QTcB Interval (Bazett's Correction Formula, QTcB) - Change From Baseline (Day -1) at Day 14</measure>
    <time_frame>Baseline (day -1) and day 14</time_frame>
    <description>Bazett-corrected QTcB interval was evaluated as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Nature and Severity of Adverse Events (AEs) up to Day 21</measure>
    <time_frame>On or after first drug administration up to end of study (Day 21).</time_frame>
    <description>An AE was defined as any untoward medical occurrence in a subject or clinical trial subject administered a medicinal product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product.&#xD;
Serious Adverse Event (SAE) is an adverse event that at any dose: Results in death, Is life-threatening (i.e. the subject was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it was more severe), Requires inpatient hospitalization or prolongation of existing hospitalization, Results in persistent or significant disability/incapacity, Is a congenital anomaly/birth defect, Is considered to be an important medical event.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Withdrawals Due to AEs up to Day 21</measure>
    <time_frame>On or after first drug administration up to end of study (Day 21)</time_frame>
    <description>An AE was defined as any untoward medical occurrence in a subject or clinical trial subject administered a medicinal product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product.&#xD;
Serious Adverse Event (SAE) is an adverse event that at any dose: Results in death, Is life-threatening (i.e. the subject was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it was more severe), Requires inpatient hospitalization or prolongation of existing hospitalization, Results in persistent or significant disability/incapacity, Is a congenital anomaly/birth defect, Is considered to be an important medical event.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Frequency of Hot Flushes From Baseline (Day -1) at Days 7, 14 as Assessed by Skin Conductance</measure>
    <time_frame>Baseline (day -1) and days 7, 14</time_frame>
    <description>Sternal skin conductance monitors (the Bahr MonitorTM) and the associated algorithm software were supplied by Simplex Scientific LLC (Middleton, USA).&#xD;
Participants were instructed to push a button on the skin conductance monitor when they sensed a hot flush when fitted with the monitor and then provide details of the hot flush in the continuous hot flush diary. Sternal skin conductance monitors were fitted on Day -1 (24 hours±1 hour prior to the planned study drug administration on Day 1) and remained in place until after the Day 7 24-hour assessments were completed (on Day 8). Refitted around 30 minutes prior to study drug administration on Day 14 and remained in place until after the 24-hour assessments were completed on Day 15.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Week -1) at Weeks 1, 2 in Frequency of Moderate to Severe Hot Flushes as Measured by Twice Daily Paper Diary Throughout Study</measure>
    <time_frame>Baseline (week -1) and Week 1 ,Week 2</time_frame>
    <description>Hot flush frequency and hot flush severity were obtained using the Hot Flush paper Diary. Subjects documented the number of individual hot flushes experienced and rated the severity of each on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3). The diaries were completed based on recall twice daily, in the morning and evening.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Week -1) at Weeks 1, 2 in Average Daily Severity of Hot Flushes as Measured by Twice Daily Paper Diary</measure>
    <time_frame>Baseline (week -1) and weeks 1, Week 2</time_frame>
    <description>Participants documented the number of individual hot flushes experienced and rated the severity of each on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3). The diaries were completed based on recall twice daily, in the morning and evening.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Week -1) at Weeks 1, 2 in Average Daily Hot Flushes Severity Score as Measured by Twice Daily Paper Diary.</measure>
    <time_frame>Baseline (week -1) and week 1 , 2</time_frame>
    <description>The hot flushes severity score was a composite of the frequency and severity of hot flushes, and was calculated as follows: number of mild hot flushes recorded on Day Y + number of moderate hot flushes recorded on Day Y × 2 + number of severe hot flushes recorded on Day Y × 3. Higher scores mean more severe hot flushes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Frequency From Baseline (Day -1), at Days 7, 14 of Hot Flushes as Measured by Continuous Day Time Diary.</measure>
    <time_frame>Baseline(day -1) and Day 7, 14</time_frame>
    <description>Subjects recorded each hot flush and its severity on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3) in the hot flush paper diary as they occurred during the day and night.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Week -1) at Weeks 1, 2 in Night-time Awakenings (NTA) Secondary to Hot Flushes as Measured by Paper Diary</measure>
    <time_frame>Baseline (week-1) and weeks 1 , 2</time_frame>
    <description>The number of NTAs secondary to hot flushes was the sum of the number of moderate and severe night-time hot flushes recorded the following morning (twice-daily hot flush diary) or recorded contemporaneously on the continuous diary.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline (Day-1) to Day 1 and Day 7 in Luteinizing Hormone (AUC0-8)</measure>
    <time_frame>baseline (day-1) to day 1 and day 7, pre-dose and post-dose (0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 8.0, 12.0 and 24.0 hours)</time_frame>
    <description>Change in Luteinizing Hormone(LH) AUC from time zero to 8 hours. Pre-dose samples for LH were taken within 30 minutes prior to dose administration.</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Post-menopausal Vasomotor Symptoms</condition>
  <arm_group>
    <arm_group_label>BAY3427080 Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>50mg BAY3427080</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>100mg BAY3427080</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>150mg BAY3427080</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>300mg BAY3427080</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BAY3427080</intervention_name>
    <arm_group_label>100mg BAY3427080</arm_group_label>
    <arm_group_label>150mg BAY3427080</arm_group_label>
    <arm_group_label>300mg BAY3427080</arm_group_label>
    <arm_group_label>50mg BAY3427080</arm_group_label>
    <other_name>NT-814</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (for BAY3427080)</intervention_name>
    <arm_group_label>BAY3427080 Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Post-menopausal female subjects experiencing frequent moderate to severe hot&#xD;
             flashes.Menopause will be defined as:&#xD;
&#xD;
               -  12 months of spontaneous amenorrhea;&#xD;
&#xD;
               -  OR at least 6 weeks' post-surgical bilateral oophorectomy with or without&#xD;
                  hysterectomy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI &gt; 35kg/m2.&#xD;
&#xD;
          -  Any active comorbid disease, ECG or laboratory result deemed by the investigator to be&#xD;
             clinically significant and which could impact safety during study conduct or that&#xD;
             could interfere with the study evaluation, procedures or completion.&#xD;
&#xD;
          -  Use of prohibited medications defined in the protocol.&#xD;
&#xD;
          -  Inability or unwillingness to comply with study procedures or requirements.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Avail Clinical Research</name>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>QPS/MRA (Miami Clinical Research)</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ICON Clinical Research Unit</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 3, 2016</study_first_submitted>
  <study_first_submitted_qc>August 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2016</study_first_posted>
  <results_first_submitted>December 18, 2020</results_first_submitted>
  <results_first_submitted_qc>January 28, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 16, 2021</results_first_posted>
  <disposition_first_submitted>October 10, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>October 10, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">October 11, 2018</disposition_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hot flashes</keyword>
  <keyword>Post-menopausal</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Availability of this study's data will be determined according to Bayer's commitment to the EFPIA/PhRMA &quot;Principles for responsible clinical trial data sharing&quot;. This pertains to scope, timepoint and process of data access. As such, Bayer commits to sharing upon request from qualified researchers patient-level clinical trial data, study-level clinical trial data, and protocols from clinical trials in patients for medicines and indications approved in the US and EU as necessary for conducting legitimate research. This applies to data on new medicines and indications that have been approved by the EU and US regulatory agencies on or after January 01, 2014. Interested researchers can use www.clinicalstudydatarequest.com to request access to anonymized patient-level data and supporting documents from clinical studies to conduct research. Information on the Bayer criteria for listing studies and other relevant information is provided in the Study sponsors section of the portal.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 13, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT02865538/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 5, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT02865538/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The study was conducted between 01 August 2016 (first subject, screening visit) and 28 March 2017 (last subject, last visit).</recruitment_details>
      <pre_assignment_details>Overall 316 subjects were screened, of them 240 were screening failure. 76 subjects were randomized and assigned to treatment. 18 subjects were randomized to placebo and 58 subjects to BAY3427080 (NT-814) arms. 2 subjects discontinued the study .</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo Comparator</title>
          <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
        </group>
        <group group_id="P2">
          <title>50 mg BAY3427080</title>
          <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
        <group group_id="P3">
          <title>100 mg BAY3427080</title>
          <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
        </group>
        <group group_id="P4">
          <title>150 mg BAY3427080</title>
          <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
        <group group_id="P5">
          <title>300 mg of BAY3427080</title>
          <description>300 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="15"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="15"/>
                <participants group_id="P5" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo Comparator</title>
          <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
        </group>
        <group group_id="B2">
          <title>50 mg BAY3427080</title>
          <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
        <group group_id="B3">
          <title>100 mg BAY3427080</title>
          <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
        </group>
        <group group_id="B4">
          <title>150 mg BAY3427080</title>
          <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
        <group group_id="B5">
          <title>300 mg of BAY3427080</title>
          <description>300 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="18"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="15"/>
            <count group_id="B4" value="15"/>
            <count group_id="B5" value="13"/>
            <count group_id="B6" value="76"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.2" spread="4.08"/>
                    <measurement group_id="B2" value="55.9" spread="5.57"/>
                    <measurement group_id="B3" value="55.3" spread="5.43"/>
                    <measurement group_id="B4" value="56.7" spread="4.37"/>
                    <measurement group_id="B5" value="53.8" spread="3.88"/>
                    <measurement group_id="B6" value="55.4" spread="4.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="13"/>
                    <measurement group_id="B6" value="76"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="10"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="11"/>
                    <measurement group_id="B6" value="62"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="73.25" spread="10.11"/>
                    <measurement group_id="B2" value="70.85" spread="11.82"/>
                    <measurement group_id="B3" value="73.47" spread="14.93"/>
                    <measurement group_id="B4" value="72.10" spread="7.10"/>
                    <measurement group_id="B5" value="72.73" spread="12.05"/>
                    <measurement group_id="B6" value="72.48" spread="11.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Maximum Observed Plasma Concentration (Cmax) of BAY3427080</title>
        <description>Cmax is the maximum observed plasma concentration of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
        <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
        <population>Participants who received placebo were not included in the PK population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Maximum Observed Plasma Concentration (Cmax) of BAY3427080</title>
          <description>Cmax is the maximum observed plasma concentration of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
          <population>Participants who received placebo were not included in the PK population.</population>
          <units>ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="502.62" spread="90.19"/>
                    <measurement group_id="O3" value="731.69" spread="110.58"/>
                    <measurement group_id="O4" value="911.48" spread="148.28"/>
                    <measurement group_id="O5" value="1576.01" spread="90.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="548.60" spread="57.47"/>
                    <measurement group_id="O3" value="809.48" spread="116.58"/>
                    <measurement group_id="O4" value="1173.50" spread="95.14"/>
                    <measurement group_id="O5" value="2045.61" spread="152.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="522.36" spread="87.88"/>
                    <measurement group_id="O3" value="841.42" spread="107.16"/>
                    <measurement group_id="O4" value="1188.19" spread="131.20"/>
                    <measurement group_id="O5" value="2851.83" spread="116.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to Reach Maximum Observed Drug Concentration in Plasma (Tmax) of BAY3427080</title>
        <description>Time of occurrence of Cmax.Time to reach maximum plasma concentration of BAY3427080 was presented. Blood samples for Tmax were taken within 30 minutes prior to dose administration.</description>
        <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
        <population>Participants who received placebo were not included in the PK population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Reach Maximum Observed Drug Concentration in Plasma (Tmax) of BAY3427080</title>
          <description>Time of occurrence of Cmax.Time to reach maximum plasma concentration of BAY3427080 was presented. Blood samples for Tmax were taken within 30 minutes prior to dose administration.</description>
          <population>Participants who received placebo were not included in the PK population.</population>
          <units>hr</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="1.360" spread="40.01"/>
                    <measurement group_id="O3" value="1.320" spread="38.79"/>
                    <measurement group_id="O4" value="1.521" spread="41.95"/>
                    <measurement group_id="O5" value="1.471" spread="63.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="1.432" spread="39.25"/>
                    <measurement group_id="O3" value="1.623" spread="43.19"/>
                    <measurement group_id="O4" value="1.536" spread="40.08"/>
                    <measurement group_id="O5" value="1.754" spread="56.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="1.265" spread="46.32"/>
                    <measurement group_id="O3" value="1.445" spread="56.71"/>
                    <measurement group_id="O4" value="1.296" spread="23.35"/>
                    <measurement group_id="O5" value="1.342" spread="33.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinity (AUC0-∞) of BAY3427080</title>
        <description>AUC from time zero extrapolated to infinity of BAY3427080 was presented. AUC0-∞ was only estimated following the Day 1 dose.</description>
        <time_frame>Day 1 (pre-dose and post-dose (0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 8.0, 12.0 and 24.0 hours)</time_frame>
        <population>Participants in PK population with available data are reported. Participants who received placebo were not included in the PK population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinity (AUC0-∞) of BAY3427080</title>
          <description>AUC from time zero extrapolated to infinity of BAY3427080 was presented. AUC0-∞ was only estimated following the Day 1 dose.</description>
          <population>Participants in PK population with available data are reported. Participants who received placebo were not included in the PK population.</population>
          <units>hr*ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="3"/>
                <count group_id="O5" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2018.68" spread="38.43"/>
                    <measurement group_id="O3" value="1545.58" spread="3.49"/>
                    <measurement group_id="O4" value="1151.87" spread="66.73"/>
                    <measurement group_id="O5" value="6249.52" spread="101.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Area Under the Concentration-time Curve (AUC) From Time Zero to the Time of the Last Quantifiable Concentration (AUC0-τ) of BAY3427080</title>
        <description>Area under the concentration-time curve (AUC) from time zero to the time of the last quantifiable concentration of BAY3427080 was presented. Blood samples for (AUC0-τ) were taken within 30 minutes prior to dose administration.</description>
        <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
        <population>Participants who received placebo were not included in the PK population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Concentration-time Curve (AUC) From Time Zero to the Time of the Last Quantifiable Concentration (AUC0-τ) of BAY3427080</title>
          <description>Area under the concentration-time curve (AUC) from time zero to the time of the last quantifiable concentration of BAY3427080 was presented. Blood samples for (AUC0-τ) were taken within 30 minutes prior to dose administration.</description>
          <population>Participants who received placebo were not included in the PK population.</population>
          <units>hr*ng/mL</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="1400.167" spread="67.87"/>
                    <measurement group_id="O3" value="2341.882" spread="71.19"/>
                    <measurement group_id="O4" value="3012.793" spread="97.74"/>
                    <measurement group_id="O5" value="6527.569" spread="70.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2506.97" spread="48.05"/>
                    <measurement group_id="O3" value="4472.76" spread="63.83"/>
                    <measurement group_id="O4" value="6202.894" spread="43.92"/>
                    <measurement group_id="O5" value="12859.660" spread="85.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2341.55" spread="64.73"/>
                    <measurement group_id="O3" value="3542.41" spread="86.34"/>
                    <measurement group_id="O4" value="5163.500" spread="88.71"/>
                    <measurement group_id="O5" value="14822.860" spread="99.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Terminal Elimination Half-life (t½) of BAY3427080</title>
        <description>Terminal elimination half-life of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
        <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
        <population>Participants in PK population with available data are reported. Participants who received placebo were not included in the PK population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Terminal Elimination Half-life (t½) of BAY3427080</title>
          <description>Terminal elimination half-life of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
          <population>Participants in PK population with available data are reported. Participants who received placebo were not included in the PK population.</population>
          <units>hr</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="2"/>
                <count group_id="O4" value="8"/>
                <count group_id="O5" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2.409" spread="34.15"/>
                    <measurement group_id="O3" value="1.903" spread="11.98"/>
                    <measurement group_id="O4" value="3.965" spread="45.94"/>
                    <measurement group_id="O5" value="3.142" spread="18.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2.443" spread="9.33"/>
                    <measurement group_id="O3" value="3.303" spread="21.20"/>
                    <measurement group_id="O4" value="3.482" spread="22.57"/>
                    <measurement group_id="O5" value="2.271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="1"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="2.698" spread="21.64"/>
                    <measurement group_id="O3" value="2.042"/>
                    <measurement group_id="O4" value="21.593" spread="24.58"/>
                    <measurement group_id="O5" value="20.427" spread="22.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Apparent Clearance (CL/F) of BAY3427080</title>
        <description>Apparent clearance of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
        <time_frame>On Day 1, Day 7 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0 hours) and on Day 14 (Pre-dose; 0.5; 1.0; 1.5; 2.0; 2.5; 3.0; 4.0; 5.0; 6.0; 8.0; 12.0; 24.0, 48.0, 72.0 hours)</time_frame>
        <population>Participants who received placebo were not included in the PK population.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Apparent Clearance (CL/F) of BAY3427080</title>
          <description>Apparent clearance of BAY3427080 was presented. Blood samples were taken within 30 minutes prior to dose administration.</description>
          <population>Participants who received placebo were not included in the PK population.</population>
          <units>L/hr</units>
          <param>Geometric Mean</param>
          <dispersion>Geometric Coefficient of Variation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="7"/>
                    <count group_id="O3" value="2"/>
                    <count group_id="O4" value="3"/>
                    <count group_id="O5" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="24.769" spread="38.43"/>
                    <measurement group_id="O3" value="64.700" spread="3.49"/>
                    <measurement group_id="O4" value="130.223" spread="66.73"/>
                    <measurement group_id="O5" value="48.004" spread="101.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="19.944" spread="48.05"/>
                    <measurement group_id="O3" value="22.358" spread="63.83"/>
                    <measurement group_id="O4" value="24.182" spread="43.92"/>
                    <measurement group_id="O5" value="23.329" spread="85.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="0"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="21.353" spread="64.73"/>
                    <measurement group_id="O3" value="28.229" spread="86.34"/>
                    <measurement group_id="O4" value="29.050" spread="88.71"/>
                    <measurement group_id="O5" value="20.239" spread="99.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Clinically Significant Abnormalities Detected Upon Physical Examination.</title>
        <description>A physician or appropriately qualified delegate conducted a full physical examination. Clinically significance was decided by investigator. The findings are presented as abnormal (clinically significant).</description>
        <time_frame>At day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinically Significant Abnormalities Detected Upon Physical Examination.</title>
          <description>A physician or appropriately qualified delegate conducted a full physical examination. Clinically significance was decided by investigator. The findings are presented as abnormal (clinically significant).</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Clinically Significant Abnormalities on the 12-lead ECGs</title>
        <description>Reported results are cardiovascular system-examination findings at day 14. Clinically significance was decided by investigator. The findings are presented as abnormal (clinically significant).</description>
        <time_frame>At day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinically Significant Abnormalities on the 12-lead ECGs</title>
          <description>Reported results are cardiovascular system-examination findings at day 14. Clinically significance was decided by investigator. The findings are presented as abnormal (clinically significant).</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Arrhythmias as Assessed by Continuous Holter Monitoring.</title>
        <description>Holter monitors were supplied by iCardiac Technologies. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14 and remained in place until 24-hour assessments were completed.</description>
        <time_frame>Baseline (day -1) and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Arrhythmias as Assessed by Continuous Holter Monitoring.</title>
          <description>Holter monitors were supplied by iCardiac Technologies. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14 and remained in place until 24-hour assessments were completed.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Average Hourly Daytime Heart Rate &lt; 50 bpm (daytime defined as 7 am-10 pm)(Day-1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Supraventricular Premature Beats (APBs) (&gt;100/24hrs) (Day-1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Ventricular Ectopic Beats (VEs) (&gt; 200/24hrs) (Day-1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other arrhythmias (Day-1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second Degree AV Block - Type I (Day-1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sinus Bradycardia (HR &lt; 40 bpm)(Day-1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SupraVentricular Tachycardia (lasting &gt; 10 beats) (Day-1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>At least three monomorphic beats in a row (Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average Hourly Daytime Heart Rate &lt; 50 bpm (daytime defined as 7 am-10 pm) (Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Supraventricular Premature Beats (APBs) (&gt;100/24hrs) (Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequent Ventricular Ectopic Beats (VEs) (&gt; 200/24hrs) (Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other arrhythmias (Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="15"/>
                    <measurement group_id="O5" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Presence of NSVT (Non-Sustained Ventricular Tachycardia) episodes (Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second Degree AV Block - Type I (Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second Degree AV Block - Type II(Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sinus Bradycardia (HR &lt; 40 bpm)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SupraVentricular Tachycardia (lasting &gt; 10 beats (Day 14)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Diastolic Blood Pressure (Standing)</title>
        <description>Diastolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in standing position.</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Diastolic Blood Pressure (Standing)</title>
          <description>Diastolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in standing position.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.11" spread="4.702"/>
                    <measurement group_id="O2" value="76.07" spread="5.257"/>
                    <measurement group_id="O3" value="77.67" spread="11.462"/>
                    <measurement group_id="O4" value="78.93" spread="6.147"/>
                    <measurement group_id="O5" value="77.92" spread="9.768"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.11" spread="9.579"/>
                    <measurement group_id="O2" value="2.53" spread="5.540"/>
                    <measurement group_id="O3" value="-0.07" spread="12.137"/>
                    <measurement group_id="O4" value="0.93" spread="7.216"/>
                    <measurement group_id="O5" value="1.62" spread="9.097"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Diastolic Blood Pressure (Sitting)</title>
        <description>Diastolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in sitting position.</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Diastolic Blood Pressure (Sitting)</title>
          <description>Diastolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in sitting position.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.72" spread="6.542"/>
                    <measurement group_id="O2" value="74.27" spread="6.239"/>
                    <measurement group_id="O3" value="77.20" spread="10.705"/>
                    <measurement group_id="O4" value="74.80" spread="6.774"/>
                    <measurement group_id="O5" value="74.15" spread="8.245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.11" spread="9.292"/>
                    <measurement group_id="O2" value="-0.53" spread="6.906"/>
                    <measurement group_id="O3" value="-0.79" spread="9.736"/>
                    <measurement group_id="O4" value="2.73" spread="9.384"/>
                    <measurement group_id="O5" value="1.77" spread="6.366"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Systolic Blood Pressure (Standing)</title>
        <description>Systolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in standing position.</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Systolic Blood Pressure (Standing)</title>
          <description>Systolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in standing position.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="117.83" spread="10.733"/>
                    <measurement group_id="O2" value="114.60" spread="8.675"/>
                    <measurement group_id="O3" value="121.33" spread="17.867"/>
                    <measurement group_id="O4" value="118.87" spread="11.513"/>
                    <measurement group_id="O5" value="114.77" spread="15.095"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.11" spread="11.483"/>
                    <measurement group_id="O2" value="3.80" spread="13.311"/>
                    <measurement group_id="O3" value="-4.43" spread="18.744"/>
                    <measurement group_id="O4" value="0.33" spread="12.234"/>
                    <measurement group_id="O5" value="5.62" spread="16.536"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Systolic Blood Pressure (Sitting)</title>
        <description>Systolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in sitting position.</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Systolic Blood Pressure (Sitting)</title>
          <description>Systolic Blood Pressure was measured just prior to dosing (approx. 30 mins) in sitting position.</description>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.39" spread="11.304"/>
                    <measurement group_id="O2" value="113.80" spread="9.405"/>
                    <measurement group_id="O3" value="119.07" spread="15.931"/>
                    <measurement group_id="O4" value="117.20" spread="10.638"/>
                    <measurement group_id="O5" value="114.15" spread="14.288"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.17" spread="11.868"/>
                    <measurement group_id="O2" value="0.20" spread="10.359"/>
                    <measurement group_id="O3" value="-2.79" spread="16.470"/>
                    <measurement group_id="O4" value="2.47" spread="16.890"/>
                    <measurement group_id="O5" value="5.62" spread="12.672"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Pulse Rate</title>
        <description>Pulse rate was measured just prior to dosing (approx. 30 mins).</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Pulse Rate</title>
          <description>Pulse rate was measured just prior to dosing (approx. 30 mins).</description>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.89" spread="8.629"/>
                    <measurement group_id="O2" value="66.00" spread="6.358"/>
                    <measurement group_id="O3" value="69.20" spread="9.966"/>
                    <measurement group_id="O4" value="68.40" spread="4.611"/>
                    <measurement group_id="O5" value="72.62" spread="7.136"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" spread="8.271"/>
                    <measurement group_id="O2" value="-2.00" spread="8.027"/>
                    <measurement group_id="O3" value="0.14" spread="7.263"/>
                    <measurement group_id="O4" value="0.27" spread="8.388"/>
                    <measurement group_id="O5" value="-11.00" spread="9.618"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Respiratory Rate</title>
        <description>Respiratory rate was measured just prior to dosing (approx. 30 mins).</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Respiratory Rate</title>
          <description>Respiratory rate was measured just prior to dosing (approx. 30 mins).</description>
          <units>breaths/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.39" spread="1.378"/>
                    <measurement group_id="O2" value="15.47" spread="1.727"/>
                    <measurement group_id="O3" value="15.73" spread="1.624"/>
                    <measurement group_id="O4" value="15.60" spread="1.502"/>
                    <measurement group_id="O5" value="15.85" spread="1.573"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.11" spread="2.220"/>
                    <measurement group_id="O2" value="-0.40" spread="2.197"/>
                    <measurement group_id="O3" value="0.07" spread="1.940"/>
                    <measurement group_id="O4" value="-0.43" spread="2.065"/>
                    <measurement group_id="O5" value="-1.33" spread="1.923"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Oxygen Saturation</title>
        <description>Oxygen Saturation was measured just prior to dosing (approx. 30 mins).</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Oxygen Saturation</title>
          <description>Oxygen Saturation was measured just prior to dosing (approx. 30 mins).</description>
          <units>Percentage of Oxygen satuartion</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.50" spread="1.098"/>
                    <measurement group_id="O2" value="98.40" spread="1.404"/>
                    <measurement group_id="O3" value="97.87" spread="1.727"/>
                    <measurement group_id="O4" value="97.67" spread="1.496"/>
                    <measurement group_id="O5" value="97.31" spread="1.251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.61" spread="1.539"/>
                    <measurement group_id="O2" value="-0.73" spread="1.486"/>
                    <measurement group_id="O3" value="0.29" spread="2.091"/>
                    <measurement group_id="O4" value="0.20" spread="1.424"/>
                    <measurement group_id="O5" value="0.38" spread="1.193"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Oral Body Temperature</title>
        <description>Temperature was measured just prior to dosing (approx. 30 mins).</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Oral Body Temperature</title>
          <description>Temperature was measured just prior to dosing (approx. 30 mins).</description>
          <units>Degree Celius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.77" spread="0.190"/>
                    <measurement group_id="O2" value="36.65" spread="0.155"/>
                    <measurement group_id="O3" value="36.79" spread="0.162"/>
                    <measurement group_id="O4" value="36.71" spread="0.168"/>
                    <measurement group_id="O5" value="36.77" spread="0.361"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.04" spread="0.243"/>
                    <measurement group_id="O2" value="0.06" spread="0.172"/>
                    <measurement group_id="O3" value="-0.09" spread="0.264"/>
                    <measurement group_id="O4" value="-0.01" spread="0.239"/>
                    <measurement group_id="O5" value="-0.05" spread="0.458"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 in Vital Signs: Weight</title>
        <description>Weight was measured just prior to dosing (approx. 30 mins).</description>
        <time_frame>Baseline and day 14</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 in Vital Signs: Weight</title>
          <description>Weight was measured just prior to dosing (approx. 30 mins).</description>
          <units>Kilograms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.25" spread="10.115"/>
                    <measurement group_id="O2" value="70.85" spread="11.821"/>
                    <measurement group_id="O3" value="73.47" spread="14.934"/>
                    <measurement group_id="O4" value="72.10" spread="7.104"/>
                    <measurement group_id="O5" value="72.73" spread="12.047"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.36" spread="1.034"/>
                    <measurement group_id="O2" value="0.51" spread="0.983"/>
                    <measurement group_id="O3" value="0.24" spread="0.916"/>
                    <measurement group_id="O4" value="0.15" spread="0.926"/>
                    <measurement group_id="O5" value="0.01" spread="0.704"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 15 for Laboratory Hormones Results : Adrenocorticotropic Hormone (ADTH) and Estradiol.</title>
        <description>Blood samples for the assessment of ACTH and Estradiol were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 15</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 15 for Laboratory Hormones Results : Adrenocorticotropic Hormone (ADTH) and Estradiol.</title>
          <description>Blood samples for the assessment of ACTH and Estradiol were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>pmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (ADTH)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.34" spread="3.402"/>
                    <measurement group_id="O2" value="4.17" spread="1.991"/>
                    <measurement group_id="O3" value="3.87" spread="2.361"/>
                    <measurement group_id="O4" value="3.55" spread="2.360"/>
                    <measurement group_id="O5" value="3.27" spread="2.011"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline (ADTH)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.49" spread="3.333"/>
                    <measurement group_id="O2" value="-0.68" spread="2.035"/>
                    <measurement group_id="O3" value="0.84" spread="1.914"/>
                    <measurement group_id="O4" value="1.04" spread="3.059"/>
                    <measurement group_id="O5" value="1.67" spread="3.059"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Estradiol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.33" spread="43.236"/>
                    <measurement group_id="O2" value="59.49" spread="40.129"/>
                    <measurement group_id="O3" value="35.02" spread="25.556"/>
                    <measurement group_id="O4" value="43.83" spread="31.270"/>
                    <measurement group_id="O5" value="62.42" spread="42.589"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline (Estradiol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.43" spread="141.618"/>
                    <measurement group_id="O2" value="13.21" spread="80.704"/>
                    <measurement group_id="O3" value="0.53" spread="3.172"/>
                    <measurement group_id="O4" value="1.96" spread="12.394"/>
                    <measurement group_id="O5" value="-9.02" spread="87.480"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 15 for Laboratory Hormones Results: Follicle Stimulating Hormone</title>
        <description>Blood samples for the assessment of Follicle Stimulating were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 15</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 15 for Laboratory Hormones Results: Follicle Stimulating Hormone</title>
          <description>Blood samples for the assessment of Follicle Stimulating were collected upon participants admission to the unit.</description>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.01" spread="23.122"/>
                    <measurement group_id="O2" value="100.87" spread="36.813"/>
                    <measurement group_id="O3" value="77.78" spread="20.132"/>
                    <measurement group_id="O4" value="88.77" spread="42.251"/>
                    <measurement group_id="O5" value="70.59" spread="17.046"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.98" spread="13.072"/>
                    <measurement group_id="O2" value="-2.29" spread="20.948"/>
                    <measurement group_id="O3" value="4.09" spread="8.353"/>
                    <measurement group_id="O4" value="6.73" spread="6.904"/>
                    <measurement group_id="O5" value="8.92" spread="13.409"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 15 for Laboratory Hormones Results : Triiodothyronine Uptake</title>
        <description>Blood samples for the assessment of Triiodothyronine were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 15</time_frame>
        <population>Participants in PK analysis set with evaluable data for this outcome measure presented.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 15 for Laboratory Hormones Results : Triiodothyronine Uptake</title>
          <description>Blood samples for the assessment of Triiodothyronine were collected upon participants admission to the unit.</description>
          <population>Participants in PK analysis set with evaluable data for this outcome measure presented.</population>
          <units>Percentage of T Uptake</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.300" spread="3.5623"/>
                    <measurement group_id="O2" value="30.800" spread="2.4712"/>
                    <measurement group_id="O3" value="30.838" spread="1.7968"/>
                    <measurement group_id="O4" value="30.671" spread="1.3060"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.720" spread="0.7662"/>
                    <measurement group_id="O2" value="-0.700" spread="0.2944"/>
                    <measurement group_id="O3" value="0.143" spread="0.7115"/>
                    <measurement group_id="O4" value="0.443" spread="1.0130"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 15 for Laboratory Hormones Results: Thyrotropin</title>
        <description>Blood samples for the assessment of Thyrotropin were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 15</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 15 for Laboratory Hormones Results: Thyrotropin</title>
          <description>Blood samples for the assessment of Thyrotropin were collected upon participants admission to the unit.</description>
          <units>mIU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.658" spread="1.7584"/>
                    <measurement group_id="O2" value="1.800" spread="0.9830"/>
                    <measurement group_id="O3" value="2.451" spread="1.4811"/>
                    <measurement group_id="O4" value="2.785" spread="1.1449"/>
                    <measurement group_id="O5" value="2.330" spread="1.2658"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.959" spread="1.3501"/>
                    <measurement group_id="O2" value="-0.571" spread="0.8148"/>
                    <measurement group_id="O3" value="-0.648" spread="0.5903"/>
                    <measurement group_id="O4" value="-0.823" spread="1.0604"/>
                    <measurement group_id="O5" value="-0.616" spread="1.1375"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 15 for Laboratory Hormones Results : Cortisol, Testosterone, Thyroxine and Triiodothyronine</title>
        <description>Blood samples for the assessment of Cortisol, Testosterone, Thyroxine and Triiodothyronine were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 15</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 15 for Laboratory Hormones Results : Cortisol, Testosterone, Thyroxine and Triiodothyronine</title>
          <description>Blood samples for the assessment of Cortisol, Testosterone, Thyroxine and Triiodothyronine were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>nmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Cortisol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="348.60" spread="156.496"/>
                    <measurement group_id="O2" value="337.16" spread="177.507"/>
                    <measurement group_id="O3" value="345.91" spread="173.302"/>
                    <measurement group_id="O4" value="251.66" spread="144.743"/>
                    <measurement group_id="O5" value="230.42" spread="74.560"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline (Cortisol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.94" spread="193.564"/>
                    <measurement group_id="O2" value="-23.32" spread="172.685"/>
                    <measurement group_id="O3" value="68.05" spread="170.121"/>
                    <measurement group_id="O4" value="92.02" spread="159.464"/>
                    <measurement group_id="O5" value="127.20" spread="208.452"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Testosterone)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.744" spread="0.3850"/>
                    <measurement group_id="O2" value="0.666" spread="0.6230"/>
                    <measurement group_id="O3" value="0.517" spread="0.2317"/>
                    <measurement group_id="O4" value="0.433" spread="0.2961"/>
                    <measurement group_id="O5" value="0.611" spread="0.4271"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline (Testosterone)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.057" spread="0.3567"/>
                    <measurement group_id="O2" value="0.024" spread="0.2578"/>
                    <measurement group_id="O3" value="0.696" spread="0.3367"/>
                    <measurement group_id="O4" value="0.480" spread="0.4589"/>
                    <measurement group_id="O5" value="0.524" spread="0.2905"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(Thyroxine)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.44" spread="14.576"/>
                    <measurement group_id="O2" value="95.66" spread="15.203"/>
                    <measurement group_id="O3" value="96.11" spread="14.645"/>
                    <measurement group_id="O4" value="86.41" spread="16.116"/>
                    <measurement group_id="O5" value="94.16" spread="22.180"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline(Thyroxine)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.78" spread="14.771"/>
                    <measurement group_id="O2" value="-1.28" spread="8.127"/>
                    <measurement group_id="O3" value="-10.67" spread="26.324"/>
                    <measurement group_id="O4" value="6.53" spread="9.546"/>
                    <measurement group_id="O5" value="0.88" spread="13.720"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(Triiodothyronine)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="7"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.865" spread="0.14131"/>
                    <measurement group_id="O2" value="2.060" spread="0.3174"/>
                    <measurement group_id="O3" value="1.980" spread="0.2916"/>
                    <measurement group_id="O4" value="1.776" spread="0.4510"/>
                    <measurement group_id="O5" value="2.163" spread="0.6008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 15 Change from Baseline (Triiodothyronine)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="12"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="7"/>
                    <count group_id="O4" value="8"/>
                    <count group_id="O5" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.190" spread="0.3171"/>
                    <measurement group_id="O2" value="-0.141" spread="0.2742"/>
                    <measurement group_id="O3" value="-0.407" spread="0.2180"/>
                    <measurement group_id="O4" value="-0.148" spread="0.1883"/>
                    <measurement group_id="O5" value="-0.416" spread="0.5359"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Clinical Laboratory Parameters LIPIDS : Cholesterol, Triglycerides, HDL Cholesterol and LDL Cholesterol.</title>
        <description>Blood samples for the assessment of Cholesterol, Triglycerides,high-density lipoprotein (HDL)Cholesterol and low-density lipoprotein (LDL) Cholesterol were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Clinical Laboratory Parameters LIPIDS : Cholesterol, Triglycerides, HDL Cholesterol and LDL Cholesterol.</title>
          <description>Blood samples for the assessment of Cholesterol, Triglycerides,high-density lipoprotein (HDL)Cholesterol and low-density lipoprotein (LDL) Cholesterol were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Cholesterol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.434" spread="1.0223"/>
                    <measurement group_id="O2" value="5.471" spread="0.6592"/>
                    <measurement group_id="O3" value="5.391" spread="0.7346"/>
                    <measurement group_id="O4" value="5.804" spread="0.6462"/>
                    <measurement group_id="O5" value="5.393" spread="0.9008"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Cholesterol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.088" spread="0.8629"/>
                    <measurement group_id="O2" value="-0.061" spread="0.4761"/>
                    <measurement group_id="O3" value="-0.205" spread="0.8981"/>
                    <measurement group_id="O4" value="-0.185" spread="0.6386"/>
                    <measurement group_id="O5" value="-0.321" spread="0.6790"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Triglycerides)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.163" spread="0.5796"/>
                    <measurement group_id="O2" value="1.185" spread="0.5036"/>
                    <measurement group_id="O3" value="1.131" spread="0.5889"/>
                    <measurement group_id="O4" value="1.329" spread="0.6245"/>
                    <measurement group_id="O5" value="1.353" spread="0.5540"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Triglycerides)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.048" spread="0.4936"/>
                    <measurement group_id="O2" value="-0.071" spread="0.4725"/>
                    <measurement group_id="O3" value="-0.116" spread="0.5247"/>
                    <measurement group_id="O4" value="-0.029" spread="0.4178"/>
                    <measurement group_id="O5" value="-0.172" spread="0.5633"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(HDL Cholesterol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.717" spread="0.4525"/>
                    <measurement group_id="O2" value="1.879" spread="0.4052"/>
                    <measurement group_id="O3" value="1.7444" spread="0.6563"/>
                    <measurement group_id="O4" value="1.768" spread="0.4716"/>
                    <measurement group_id="O5" value="1.449" spread="0.2752"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline( HDL Cholesterol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.167" spread="0.2824"/>
                    <measurement group_id="O2" value="-0.219" spread="0.2015"/>
                    <measurement group_id="O3" value="-0.056" spread="0.2559"/>
                    <measurement group_id="O4" value="-0.147" spread="0.1546"/>
                    <measurement group_id="O5" value="-0.158" spread="0.3132"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline( LDL Cholesterol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.226" spread="1.0485"/>
                    <measurement group_id="O2" value="3.125" spread="0.8436"/>
                    <measurement group_id="O3" value="3.172" spread="0.7654"/>
                    <measurement group_id="O4" value="3.625" spread="0.7188"/>
                    <measurement group_id="O5" value="3.552" spread="1.1088"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline ( LDL Cholesterol)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.013" spread="0.3926"/>
                    <measurement group_id="O2" value="0.184" spread="0.2958"/>
                    <measurement group_id="O3" value="-0.119" spread="0.6747"/>
                    <measurement group_id="O4" value="-0.038" spread="0.6490"/>
                    <measurement group_id="O5" value="-0.053" spread="0.5944"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils and Immature Granulocytes.</title>
        <description>Blood samples for the assessment of Neutrophils/Leukocytes, Lymphocytes /Leukocytes, Monocytes/Leukocytes, Eosinophils/Leukocytes, Basophils/Leukocytes and Immature Granulocytes/ Leukocytes were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils and Immature Granulocytes.</title>
          <description>Blood samples for the assessment of Neutrophils/Leukocytes, Lymphocytes /Leukocytes, Monocytes/Leukocytes, Eosinophils/Leukocytes, Basophils/Leukocytes and Immature Granulocytes/ Leukocytes were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>Percentage of total white blood cells</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Neutrophils/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.53" spread="7.700"/>
                    <measurement group_id="O2" value="53.31" spread="4.994"/>
                    <measurement group_id="O3" value="55.65" spread="8.318"/>
                    <measurement group_id="O4" value="54.78" spread="8.610"/>
                    <measurement group_id="O5" value="50.92" spread="10.316"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Neutrophils/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.29" spread="7.788"/>
                    <measurement group_id="O2" value="2.41" spread="6.119"/>
                    <measurement group_id="O3" value="-0.50" spread="5.047"/>
                    <measurement group_id="O4" value="-0.98" spread="7.116"/>
                    <measurement group_id="O5" value="-2.69" spread="10.614"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Lymphocytes/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.40" spread="7.098"/>
                    <measurement group_id="O2" value="35.57" spread="5.439"/>
                    <measurement group_id="O3" value="33.33" spread="8.024"/>
                    <measurement group_id="O4" value="34.33" spread="7.444"/>
                    <measurement group_id="O5" value="36.78" spread="10.446"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline(Lymphocytes / Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="5.791"/>
                    <measurement group_id="O2" value="-2.46" spread="5.667"/>
                    <measurement group_id="O3" value="-0.11" spread="4.763"/>
                    <measurement group_id="O4" value="0.59" spread="5.835"/>
                    <measurement group_id="O5" value="2.75" spread="10.926"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline ( Monocytes / Leukocytes )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.58" spread="1.592"/>
                    <measurement group_id="O2" value="7.47" spread="1.379"/>
                    <measurement group_id="O3" value="7.62" spread="1.591"/>
                    <measurement group_id="O4" value="7.71" spread="1.762"/>
                    <measurement group_id="O5" value="8.62" spread="3.276"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline( Monocytes/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="1.947"/>
                    <measurement group_id="O2" value="-0.15" spread="1.751"/>
                    <measurement group_id="O3" value="0.65" spread="1.291"/>
                    <measurement group_id="O4" value="0.05" spread="2.758"/>
                    <measurement group_id="O5" value="0.22" spread="3.850"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline ( Eosinophils/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.83" spread="2.433"/>
                    <measurement group_id="O2" value="3.04" spread="3.352"/>
                    <measurement group_id="O3" value="2.64" spread="1.422"/>
                    <measurement group_id="O4" value="2.61" spread="1.170"/>
                    <measurement group_id="O5" value="3.05" spread="1.979"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline(Eosinophils/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="1.316"/>
                    <measurement group_id="O2" value="0.29" spread="0.961"/>
                    <measurement group_id="O3" value="0.06" spread="0.794"/>
                    <measurement group_id="O4" value="0.33" spread="0.538"/>
                    <measurement group_id="O5" value="-0.24" spread="1.189"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(Basophils/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.61" spread="0.263"/>
                    <measurement group_id="O2" value="0.55" spread="0.177"/>
                    <measurement group_id="O3" value="0.66" spread="0.295"/>
                    <measurement group_id="O4" value="0.51" spread="0.223"/>
                    <measurement group_id="O5" value="0.56" spread="0.373"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Basophils/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.13" spread="0.181"/>
                    <measurement group_id="O2" value="-0.07" spread="0.111"/>
                    <measurement group_id="O3" value="-0.14" spread="0.122"/>
                    <measurement group_id="O4" value="0.01" spread="0.209"/>
                    <measurement group_id="O5" value="-0.05" spread="0.307"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline( Immature Granulocytes/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.15" spread="0.084"/>
                    <measurement group_id="O2" value="0.25" spread="0.100"/>
                    <measurement group_id="O3" value="0.20" spread="0.151"/>
                    <measurement group_id="O4" value="0.13" spread="0.111"/>
                    <measurement group_id="O5" value="0.15" spread="0.084"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline( Immature Granulocytes/ Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="7"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.082"/>
                    <measurement group_id="O2" value="-0.05" spread="0.100"/>
                    <measurement group_id="O3" value="0.09" spread="0.157"/>
                    <measurement group_id="O4" value="0.00" spread="0.183"/>
                    <measurement group_id="O5" value="0.03" spread="0.137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Clinical Laboratory Parameters HEMATOLOGY: Leukocytes, Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils, Immature Granulocytes and Platelets.</title>
        <description>Blood samples for the assessment of Leukocytes, Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils, Immature Granulocytes and Platelets were collected upon participant's admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Clinical Laboratory Parameters HEMATOLOGY: Leukocytes, Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils, Immature Granulocytes and Platelets.</title>
          <description>Blood samples for the assessment of Leukocytes, Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils, Immature Granulocytes and Platelets were collected upon participant's admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>10^9*cells/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline( Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.73" spread="1.372"/>
                    <measurement group_id="O2" value="6.54" spread="1.613"/>
                    <measurement group_id="O3" value="6.75" spread="1.245"/>
                    <measurement group_id="O4" value="6.78" spread="1.307"/>
                    <measurement group_id="O5" value="6.60" spread="1.896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline( Leukocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.60" spread="1.299"/>
                    <measurement group_id="O2" value="-0.27" spread="1.134"/>
                    <measurement group_id="O3" value="-0.34" spread="0.686"/>
                    <measurement group_id="O4" value="-0.80" spread="1.011"/>
                    <measurement group_id="O5" value="-0.06" spread="1.650"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Neutrophils)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.847" spread="1.0899"/>
                    <measurement group_id="O2" value="3.493" spread="0.9737"/>
                    <measurement group_id="O3" value="3.779" spread="0.9332"/>
                    <measurement group_id="O4" value="3.745" spread="0.9686"/>
                    <measurement group_id="O5" value="3.394" spread="1.3264"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Neutrophils )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.374" spread="1.1794"/>
                    <measurement group_id="O2" value="0.072" spread="0.7422"/>
                    <measurement group_id="O3" value="-0.246" spread="0.5487"/>
                    <measurement group_id="O4" value="-0.539" spread="0.9017"/>
                    <measurement group_id="O5" value="-0.186" spread="1.4444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Lymphocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.148" spread="0.4905"/>
                    <measurement group_id="O2" value="2.341" spread="0.7009"/>
                    <measurement group_id="O3" value="2.242" spread="0.6199"/>
                    <measurement group_id="O4" value="2.320" spread="0.6467"/>
                    <measurement group_id="O5" value="2.429" spread="0.9032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Lymphocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.172" spread="0.2900"/>
                    <measurement group_id="O2" value="-0.301" spread="0.5336"/>
                    <measurement group_id="O3" value="-0.107" spread="0.3652"/>
                    <measurement group_id="O4" value="-0.237" spread="0.3901"/>
                    <measurement group_id="O5" value="0.142" spread="0.6749"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline ( Monocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.499" spread="0.0984"/>
                    <measurement group_id="O2" value="0.479" spread="0.1051"/>
                    <measurement group_id="O3" value="0.505" spread="0.0990"/>
                    <measurement group_id="O4" value="0.524" spread="0.1410"/>
                    <measurement group_id="O5" value="0.534" spread="0.1552"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline( Monocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.033" spread="0.1117"/>
                    <measurement group_id="O2" value="-0.030" spread="0.1324"/>
                    <measurement group_id="O3" value="0.019" spread="0.0895"/>
                    <measurement group_id="O4" value="-0.057" spread="0.1941"/>
                    <measurement group_id="O5" value="0.002" spread="0.1643"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline ( Eosinophils)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.202" spread="0.2325"/>
                    <measurement group_id="O2" value="0.185" spread="0.1814"/>
                    <measurement group_id="O3" value="0.177" spread="0.1090"/>
                    <measurement group_id="O4" value="0.177" spread="0.0954"/>
                    <measurement group_id="O5" value="0.208" spread="0.1592"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline(Eosinophils)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.017" spread="0.0995"/>
                    <measurement group_id="O2" value="0.021" spread="0.0719"/>
                    <measurement group_id="O3" value="-0.006" spread="0.0549"/>
                    <measurement group_id="O4" value="0.005" spread="0.0436"/>
                    <measurement group_id="O5" value="-0.028" spread="0.1155"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(Basophils)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.041" spread="0.0305"/>
                    <measurement group_id="O2" value="0.031" spread="0.0264"/>
                    <measurement group_id="O3" value="0.028" spread="0.0321"/>
                    <measurement group_id="O4" value="0.027" spread="0.0301"/>
                    <measurement group_id="O5" value="0.030" spread="0.327"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline(Basophils)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.008" spread="0.0148"/>
                    <measurement group_id="O2" value="-0.007" spread="0.0090"/>
                    <measurement group_id="O3" value="-0.001" spread="0.0305"/>
                    <measurement group_id="O4" value="-0.010" spread="0.0259"/>
                    <measurement group_id="O5" value="-0.002" spread="0.0060"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline( Immature Granulocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                    <measurement group_id="O4" value="0.00" spread="0.00"/>
                    <measurement group_id="O5" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline( Immature Granulocytes)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="7"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                    <measurement group_id="O3" value="0.00" spread="0.00"/>
                    <measurement group_id="O4" value="0.00" spread="0.00"/>
                    <measurement group_id="O5" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Platelets )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="263.4" spread="59.66"/>
                    <measurement group_id="O2" value="249.1" spread="61.67"/>
                    <measurement group_id="O3" value="269.8" spread="61.40"/>
                    <measurement group_id="O4" value="261.9" spread="46.91"/>
                    <measurement group_id="O5" value="258.2" spread="52.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline(Platelets )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="17.77"/>
                    <measurement group_id="O2" value="4.5" spread="33.83"/>
                    <measurement group_id="O3" value="13.5" spread="29.67"/>
                    <measurement group_id="O4" value="21.6" spread="24.58"/>
                    <measurement group_id="O5" value="20.8" spread="74.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Hemoglobin and Erythrocytes Mean Corpuscular Hemoglobin Concentration</title>
        <description>Blood samples for the assessment of Hemoglobin and Erythrocytes Mean Corpuscular Hemoglobin (HB)concentration were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Hemoglobin and Erythrocytes Mean Corpuscular Hemoglobin Concentration</title>
          <description>Blood samples for the assessment of Hemoglobin and Erythrocytes Mean Corpuscular Hemoglobin (HB)concentration were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Hemoglobin)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128.9" spread="8.53"/>
                    <measurement group_id="O2" value="132.4" spread="10.64"/>
                    <measurement group_id="O3" value="128.7" spread="7.82"/>
                    <measurement group_id="O4" value="127.7" spread="8.60"/>
                    <measurement group_id="O5" value="132.2" spread="12.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Hemoglobin)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.8" spread="4.99"/>
                    <measurement group_id="O2" value="-9.0" spread="7.14"/>
                    <measurement group_id="O3" value="-14.6" spread="5.98"/>
                    <measurement group_id="O4" value="-13.9" spread="4.66"/>
                    <measurement group_id="O5" value="-12.1" spread="6.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Erythrocytes Mean Corpuscular HB concentration )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="328.5" spread="10.30"/>
                    <measurement group_id="O2" value="335.2" spread="9.42"/>
                    <measurement group_id="O3" value="329.0" spread="10.22"/>
                    <measurement group_id="O4" value="328.2" spread="7.51"/>
                    <measurement group_id="O5" value="326.8" spread="10.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Erythrocytes Mean Corpuscular HB concentration)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="5.21"/>
                    <measurement group_id="O2" value="-2.5" spread="2.34"/>
                    <measurement group_id="O3" value="-2.3" spread="6.94"/>
                    <measurement group_id="O4" value="-0.8" spread="3.41"/>
                    <measurement group_id="O5" value="3.2" spread="4.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes</title>
        <description>Blood samples for the assessment of Erythrocytes were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes</title>
          <description>Blood samples for the assessment of Erythrocytes were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>10^12*cells/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.467" spread="0.2503"/>
                    <measurement group_id="O2" value="4.525" spread="0.2212"/>
                    <measurement group_id="O3" value="4.459" spread="0.2962"/>
                    <measurement group_id="O4" value="4.365" spread="0.3678"/>
                    <measurement group_id="O5" value="4.518" spread="0.2368"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.421" spread="0.1750"/>
                    <measurement group_id="O2" value="-0.301" spread="0.2694"/>
                    <measurement group_id="O3" value="-0.511" spread="0.2111"/>
                    <measurement group_id="O4" value="-0.485" spread="0.1903"/>
                    <measurement group_id="O5" value="-0.425" spread="0.2297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Mean Corpuscular Volume and Mean Platelet Volume.</title>
        <description>Blood samples for the assessment of Erythrocytes Mean Corpuscular Volume and Mean Platelet Volume were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Mean Corpuscular Volume and Mean Platelet Volume.</title>
          <description>Blood samples for the assessment of Erythrocytes Mean Corpuscular Volume and Mean Platelet Volume were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>fL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Erythrocytes Mean Corpuscular Volume )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.87" spread="5.707"/>
                    <measurement group_id="O2" value="87.69" spread="3.890"/>
                    <measurement group_id="O3" value="87.71" spread="4.717"/>
                    <measurement group_id="O4" value="89.42" spread="6.744"/>
                    <measurement group_id="O5" value="88.63" spread="3.150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Erythrocytes Mean Corpuscular Volume )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.44" spread="1.155"/>
                    <measurement group_id="O2" value="0.11" spread="0.799"/>
                    <measurement group_id="O3" value="0.47" spread="0.967"/>
                    <measurement group_id="O4" value="0.49" spread="1,691"/>
                    <measurement group_id="O5" value="-0.27" spread="0.659"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Mean Platelet Volume)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.79" spread="0.809"/>
                    <measurement group_id="O2" value="9.91" spread="1.608"/>
                    <measurement group_id="O3" value="10.22" spread="1.565"/>
                    <measurement group_id="O4" value="10.19" spread="1.005"/>
                    <measurement group_id="O5" value="10.05" spread="1.179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Mean Platelet Volume)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14" spread="0.448"/>
                    <measurement group_id="O2" value="0.08" spread="0.412"/>
                    <measurement group_id="O3" value="-0.24" spread="0.220"/>
                    <measurement group_id="O4" value="-0.37" spread="0.403"/>
                    <measurement group_id="O5" value="-0.06" spread="0.216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Mean Corpuscular Hemoglobin</title>
        <description>Blood samples for the assessment of Erythrocytes Mean Corpuscular Hemoglobin were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Mean Corpuscular Hemoglobin</title>
          <description>Blood samples for the assessment of Erythrocytes Mean Corpuscular Hemoglobin were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>pg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.89" spread="2.517"/>
                    <measurement group_id="O2" value="29.50" spread="1.803"/>
                    <measurement group_id="O3" value="28.79" spread="2.217"/>
                    <measurement group_id="O4" value="29.39" spread="2.511"/>
                    <measurement group_id="O5" value="28.89" spread="1.759"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.494"/>
                    <measurement group_id="O2" value="-0.19" spread="0.263"/>
                    <measurement group_id="O3" value="0.03" spread="0.486"/>
                    <measurement group_id="O4" value="0.15" spread="0.532"/>
                    <measurement group_id="O5" value="0.17" spread="0.317"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Distribution Width.</title>
        <description>Blood samples for the assessment of Erythrocytes Distribution Width were collected upon participants admission to the unit. Erythrocytes distribution width (in percentage) = 1 SD of Erythrocyte volume/MCV x 100%</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Erythrocytes Distribution Width.</title>
          <description>Blood samples for the assessment of Erythrocytes Distribution Width were collected upon participants admission to the unit. Erythrocytes distribution width (in percentage) = 1 SD of Erythrocyte volume/MCV x 100%</description>
          <population>Participants with available data reported.</population>
          <units>Percentage of Erythrocyte volume</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="12"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.81" spread="15.478"/>
                    <measurement group_id="O2" value="25.52" spread="15.413"/>
                    <measurement group_id="O3" value="35.82" spread="16.476"/>
                    <measurement group_id="O4" value="30.59" spread="16.089"/>
                    <measurement group_id="O5" value="31.48" spread="17.013"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="11"/>
                    <count group_id="O3" value="11"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.916"/>
                    <measurement group_id="O2" value="0.49" spread="0.863"/>
                    <measurement group_id="O3" value="-0.05" spread="1.878"/>
                    <measurement group_id="O4" value="-0.61" spread="0.696"/>
                    <measurement group_id="O5" value="-0.68" spread="0.778"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Hematocrit.</title>
        <description>Blood samples for the assessment of Hematocrit were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters HEMATOLOGY: Hematocrit.</title>
          <description>Blood samples for the assessment of Hematocrit were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>Volume percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.18" spread="1.976"/>
                    <measurement group_id="O2" value="39.63" spread="2.461"/>
                    <measurement group_id="O3" value="38.99" spread="1.788"/>
                    <measurement group_id="O4" value="38.85" spread="1.990"/>
                    <measurement group_id="O5" value="40.02" spread="2.646"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.51" spread="1.307"/>
                    <measurement group_id="O2" value="-2.45" spread="2.106"/>
                    <measurement group_id="O3" value="-4.20" spread="1.877"/>
                    <measurement group_id="O4" value="-4.13" spread="1.431"/>
                    <measurement group_id="O5" value="-3.86" spread="2.163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Protein and Albumin.</title>
        <description>Blood samples for the assessment of Protein and Albumin were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Protein and Albumin.</title>
          <description>Blood samples for the assessment of Protein and Albumin were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Protein)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.8" spread="4.54"/>
                    <measurement group_id="O2" value="72.2" spread="4.13"/>
                    <measurement group_id="O3" value="74.3" spread="4.25"/>
                    <measurement group_id="O4" value="70.5" spread="4.84"/>
                    <measurement group_id="O5" value="69.2" spread="4.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline(Protein)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.0" spread="3.11"/>
                    <measurement group_id="O2" value="-2.5" spread="4.39"/>
                    <measurement group_id="O3" value="-6.9" spread="4.89"/>
                    <measurement group_id="O4" value="-4.1" spread="2.64"/>
                    <measurement group_id="O5" value="-2.5" spread="3.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(Albumin)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.9" spread="6.75"/>
                    <measurement group_id="O2" value="44.3" spread="1.84"/>
                    <measurement group_id="O3" value="44.4" spread="2.53"/>
                    <measurement group_id="O4" value="44.7" spread="2.53"/>
                    <measurement group_id="O5" value="43.2" spread="2.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Albumin)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="6.42"/>
                    <measurement group_id="O2" value="-2.5" spread="2.42"/>
                    <measurement group_id="O3" value="-3.2" spread="2.08"/>
                    <measurement group_id="O4" value="0.3" spread="2.05"/>
                    <measurement group_id="O5" value="-1.8" spread="2.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Alkaline Phosphatase, Alanine Aminotransferase, Aspartate Aminotransferase, Gamma Glutamyl Transferase and Creatine Kinase</title>
        <description>Blood samples for the assessment of Alkaline Phosphatase, Alanine Aminotransferase, Aspartate Aminotransferase, Gamma Glutamyl Transferase and Creatine Kinase were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Alkaline Phosphatase, Alanine Aminotransferase, Aspartate Aminotransferase, Gamma Glutamyl Transferase and Creatine Kinase</title>
          <description>Blood samples for the assessment of Alkaline Phosphatase, Alanine Aminotransferase, Aspartate Aminotransferase, Gamma Glutamyl Transferase and Creatine Kinase were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>ukat/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Alkaline Phosphatase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.587" spread="0.4829"/>
                    <measurement group_id="O2" value="1.397" spread="0.3233"/>
                    <measurement group_id="O3" value="1.364" spread="0.3219"/>
                    <measurement group_id="O4" value="1.397" spread="0.3271"/>
                    <measurement group_id="O5" value="1.407" spread="0.4417"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Alkaline Phosphatase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.129" spread="0.3411"/>
                    <measurement group_id="O2" value="-0.130" spread="0.2054"/>
                    <measurement group_id="O3" value="-0.172" spread="0.1533"/>
                    <measurement group_id="O4" value="-0.203" spread="0.2576"/>
                    <measurement group_id="O5" value="-0.131" spread="0.2958"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(Alanine Aminotransferase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.295" spread="0.1302"/>
                    <measurement group_id="O2" value="0.331" spread="0.1494"/>
                    <measurement group_id="O3" value="0.279" spread="0.1151"/>
                    <measurement group_id="O4" value="0.313" spread="0.1281"/>
                    <measurement group_id="O5" value="0.413" spread="0.1755"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Alanine Aminotransferase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.108" spread="0.4103"/>
                    <measurement group_id="O2" value="-0.049" spread="0.1053"/>
                    <measurement group_id="O3" value="0.049" spread="0,2099"/>
                    <measurement group_id="O4" value="-0.016" spread="0.1391"/>
                    <measurement group_id="O5" value="0.052" spread="0.3923"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Aspartate Aminotransferase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.344" spread="0.0760"/>
                    <measurement group_id="O2" value="0.355" spread="0.0632"/>
                    <measurement group_id="O3" value="0.343" spread="0.0950"/>
                    <measurement group_id="O4" value="0.352" spread="0.0737"/>
                    <measurement group_id="O5" value="0.401" spread="0.1976"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Aspartate Aminotransferase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.041" spread="0.2197"/>
                    <measurement group_id="O2" value="-0.035" spread="0.0542"/>
                    <measurement group_id="O3" value="-0.032" spread="0.1030"/>
                    <measurement group_id="O4" value="-0.009" spread="0.0743"/>
                    <measurement group_id="O5" value="-0.032" spread="0.2851"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Gamma Glutamyl Transferase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.309" spread="0.1740"/>
                    <measurement group_id="O2" value="0.324" spread="0.2085"/>
                    <measurement group_id="O3" value="0.397" spread="0.2111"/>
                    <measurement group_id="O4" value="0.561" spread="0.7998"/>
                    <measurement group_id="O5" value="0.372" spread="0.2272"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Gamma Glutamyl Transferase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.101" spread="0.3890"/>
                    <measurement group_id="O2" value="-0.035" spread="0.0980"/>
                    <measurement group_id="O3" value="0.001" spread="0.1606"/>
                    <measurement group_id="O4" value="-0.190" spread="0.4620"/>
                    <measurement group_id="O5" value="0.015" spread="0.1959"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Creatine Kinase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.957" spread="0.8872"/>
                    <measurement group_id="O2" value="2.047" spread="1.0146"/>
                    <measurement group_id="O3" value="1.907" spread="1.1933"/>
                    <measurement group_id="O4" value="1.895" spread="1.2638"/>
                    <measurement group_id="O5" value="1.886" spread="1.1854"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Creatine Kinase)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.021" spread="0.9758"/>
                    <measurement group_id="O2" value="-0.260" spread="0.4338"/>
                    <measurement group_id="O3" value="-0.252" spread="0.5078"/>
                    <measurement group_id="O4" value="-0.038" spread="0.5689"/>
                    <measurement group_id="O5" value="-0.269" spread="0.5032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Urate, Bilirubin and Creatinine.</title>
        <description>Blood samples for the assessment of Urate, Bilirubin and Creatinine were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Laboratory Parameters CHEMISTRY: Urate, Bilirubin and Creatinine.</title>
          <description>Blood samples for the assessment of Urate, Bilirubin and Creatinine were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Urate)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="297.43" spread="41.896"/>
                    <measurement group_id="O2" value="318.23" spread="20.323"/>
                    <measurement group_id="O3" value="261.74" spread="57.222"/>
                    <measurement group_id="O4" value="275.34" spread="75.528"/>
                    <measurement group_id="O5" value="212.17" spread="52.885"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Urate)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="4"/>
                    <count group_id="O3" value="7"/>
                    <count group_id="O4" value="7"/>
                    <count group_id="O5" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.90" spread="41.380"/>
                    <measurement group_id="O2" value="-2.95" spread="28.511"/>
                    <measurement group_id="O3" value="2.57" spread="19.706"/>
                    <measurement group_id="O4" value="-12.76" spread="28.636"/>
                    <measurement group_id="O5" value="-7.93" spread="44.269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Bilirubin)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.61" spread="3.500"/>
                    <measurement group_id="O2" value="8.44" spread="3.640"/>
                    <measurement group_id="O3" value="7.19" spread="2.932"/>
                    <measurement group_id="O4" value="6.96" spread="2.652"/>
                    <measurement group_id="O5" value="7.23" spread="3.305"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline(Bilirubin)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.25" spread="3.225"/>
                    <measurement group_id="O2" value="-1.15" spread="2.654"/>
                    <measurement group_id="O3" value="-1.00" spread="1.886"/>
                    <measurement group_id="O4" value="-0.01" spread="2.599"/>
                    <measurement group_id="O5" value="0.40" spread="3.069"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(Creatinine)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.162" spread="11.3215"/>
                    <measurement group_id="O2" value="67.125" spread="8.0711"/>
                    <measurement group_id="O3" value="65.121" spread="9.8867"/>
                    <measurement group_id="O4" value="67.891" spread="9.1636"/>
                    <measurement group_id="O5" value="11.844" spread="8.9096"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline(Creatinine)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.652" spread="6.4810"/>
                    <measurement group_id="O2" value="-1.885" spread="7.8090"/>
                    <measurement group_id="O3" value="-4.168" spread="7.6761"/>
                    <measurement group_id="O4" value="-1.297" spread="6.6136"/>
                    <measurement group_id="O5" value="-3.605" spread="5.6665"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for Clinical Laboratory Parameters CHEMISTRY: Sodium, Potassium, Chloride, Bicarbonate, Calcium, Phosphate, Glucose, Magnesium and Urea Nitrogen.</title>
        <description>Blood samples for the assessment of Sodium, Potassium, Chloride, Bicarbonate, Calcium, Phosphate, Glucose, Magnesium and Urea Nitrogen were collected upon participant's admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for Clinical Laboratory Parameters CHEMISTRY: Sodium, Potassium, Chloride, Bicarbonate, Calcium, Phosphate, Glucose, Magnesium and Urea Nitrogen.</title>
          <description>Blood samples for the assessment of Sodium, Potassium, Chloride, Bicarbonate, Calcium, Phosphate, Glucose, Magnesium and Urea Nitrogen were collected upon participant's admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Sodium)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140.7" spread="2.93"/>
                    <measurement group_id="O2" value="140.3" spread="2.05"/>
                    <measurement group_id="O3" value="140.0" spread="1.65"/>
                    <measurement group_id="O4" value="142.3" spread="3.01"/>
                    <measurement group_id="O5" value="140.0" spread="2.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Sodium)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="2.91"/>
                    <measurement group_id="O2" value="-0.7" spread="2.97"/>
                    <measurement group_id="O3" value="-0.5" spread="2.28"/>
                    <measurement group_id="O4" value="-2.5" spread="3.23"/>
                    <measurement group_id="O5" value="0.7" spread="3.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Potassium)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.41" spread="0.375"/>
                    <measurement group_id="O2" value="4.22" spread="0.246"/>
                    <measurement group_id="O3" value="4.29" spread="0.374"/>
                    <measurement group_id="O4" value="4.49" spread="0.380"/>
                    <measurement group_id="O5" value="4.14" spread="0.421"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Potassium)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.06" spread="0.478"/>
                    <measurement group_id="O2" value="0.22" spread="0.323"/>
                    <measurement group_id="O3" value="0.15" spread="0.427"/>
                    <measurement group_id="O4" value="-0.06" spread="0.408"/>
                    <measurement group_id="O5" value="0.31" spread="0.614"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Chloride)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="102.8" spread="2.94"/>
                    <measurement group_id="O2" value="102.4" spread="3.79"/>
                    <measurement group_id="O3" value="100.7" spread="2.32"/>
                    <measurement group_id="O4" value="102.7" spread="2.84"/>
                    <measurement group_id="O5" value="101.4" spread="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline ( Chloride)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="3.20"/>
                    <measurement group_id="O2" value="0.4" spread="3.16"/>
                    <measurement group_id="O3" value="1.1" spread="1.69"/>
                    <measurement group_id="O4" value="-1.1" spread="3.02"/>
                    <measurement group_id="O5" value="0.8" spread="2.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Bicarbonate)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.39" spread="2.615"/>
                    <measurement group_id="O2" value="26.60" spread="2.131"/>
                    <measurement group_id="O3" value="27.47" spread="1.642"/>
                    <measurement group_id="O4" value="26.20" spread="1.699"/>
                    <measurement group_id="O5" value="27.62" spread="3.641"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Bicarbonate)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.11" spread="3.660"/>
                    <measurement group_id="O2" value="-0.93" spread="3.575"/>
                    <measurement group_id="O3" value="1.00" spread="3.088"/>
                    <measurement group_id="O4" value="2.00" spread="2.204"/>
                    <measurement group_id="O5" value="0.31" spread="2.626"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Calcium)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.421" spread="0.0803"/>
                    <measurement group_id="O2" value="2.401" spread="0.0730"/>
                    <measurement group_id="O3" value="2.515" spread="0.0998"/>
                    <measurement group_id="O4" value="2.411" spread="0.0622"/>
                    <measurement group_id="O5" value="2.382" spread="0.0928"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Calcium)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.032" spread="0.1198"/>
                    <measurement group_id="O2" value="-0.044" spread="0.1355"/>
                    <measurement group_id="O3" value="-0.144" spread="0.1147"/>
                    <measurement group_id="O4" value="-0.049" spread="0.0630"/>
                    <measurement group_id="O5" value="-0.052" spread="0.1103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Phosphate)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.240" spread="0.1510"/>
                    <measurement group_id="O2" value="1.249" spread="0.1277"/>
                    <measurement group_id="O3" value="1.268" spread="0.1269"/>
                    <measurement group_id="O4" value="1.280" spread="0.1115"/>
                    <measurement group_id="O5" value="1.272" spread="0.1544"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Phosphate)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.026" spread="0.1602"/>
                    <measurement group_id="O2" value="-0.045" spread="0.1457"/>
                    <measurement group_id="O3" value="-0.052" spread="0.1096"/>
                    <measurement group_id="O4" value="0.027" spread="0.1389"/>
                    <measurement group_id="O5" value="-0.038" spread="0.2171"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Glucose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.457" spread="0.6417"/>
                    <measurement group_id="O2" value="5.521" spread="0.4157"/>
                    <measurement group_id="O3" value="5.349" spread="0.4957"/>
                    <measurement group_id="O4" value="5.483" spread="0.3943"/>
                    <measurement group_id="O5" value="5.456" spread="0.4401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Glucose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.113" spread="0.9083"/>
                    <measurement group_id="O2" value="-0.278" spread="0.4006"/>
                    <measurement group_id="O3" value="-0.173" spread="0.3412"/>
                    <measurement group_id="O4" value="-0.098" spread="0.4245"/>
                    <measurement group_id="O5" value="0.025" spread="0.3063"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Magnesium)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.893" spread="0.0732"/>
                    <measurement group_id="O2" value="0.885" spread="0.0588"/>
                    <measurement group_id="O3" value="0.881" spread="0.0675"/>
                    <measurement group_id="O4" value="0.905" spread="0.0703"/>
                    <measurement group_id="O5" value="0.896" spread="0.0836"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Magnesium)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.009" spread="0.0460"/>
                    <measurement group_id="O2" value="0.001" spread="0.0387"/>
                    <measurement group_id="O3" value="0.001" spread="0.0529"/>
                    <measurement group_id="O4" value="0.006" spread="0.0484"/>
                    <measurement group_id="O5" value="-0.027" spread="0.0696"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline (Urea Nitrogen)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.59" spread="1.230"/>
                    <measurement group_id="O2" value="5.47" spread="1.337"/>
                    <measurement group_id="O3" value="4.67" spread="1.274"/>
                    <measurement group_id="O4" value="5.30" spread="1.198"/>
                    <measurement group_id="O5" value="5.21" spread="1.393"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Urea Nitrogen)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="2.359"/>
                    <measurement group_id="O2" value="-0.14" spread="1.070"/>
                    <measurement group_id="O3" value="0.20" spread="0.826"/>
                    <measurement group_id="O4" value="0.00" spread="1.442"/>
                    <measurement group_id="O5" value="-0.38" spread="1.488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Laboratory Parameters CHEMISTRY: Glomerular Filtration Rate African at Baseline</title>
        <description>Blood samples for the assessment of Glomerular Filtration Rate African were collected upon participants admission to the unit.</description>
        <time_frame>At Baseline</time_frame>
        <population>Participants with available data reported. Baseline is the last available measurement prior to the first dose of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Laboratory Parameters CHEMISTRY: Glomerular Filtration Rate African at Baseline</title>
          <description>Blood samples for the assessment of Glomerular Filtration Rate African were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported. Baseline is the last available measurement prior to the first dose of study drug.</population>
          <units>mL/sec/1.73m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.628" spread="0.2347"/>
                    <measurement group_id="O2" value="1.759" spread="0.1592"/>
                    <measurement group_id="O3" value="1.580" spread="0.1846"/>
                    <measurement group_id="O4" value="1.557" spread="0.1553"/>
                    <measurement group_id="O5" value="1.666" spread="0.1885"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Laboratory Parameters CHEMISTRY: Glomerular Filtration Rate Caucasian at Baseline</title>
        <description>Blood samples for the assessment of Glomerular Filtration Rate Caucasian were collected upon participants admission to the unit.</description>
        <time_frame>At Baseline</time_frame>
        <population>Participants with available data reported. Baseline is the last available measurement prior to the first dose of study drug.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Laboratory Parameters CHEMISTRY: Glomerular Filtration Rate Caucasian at Baseline</title>
          <description>Blood samples for the assessment of Glomerular Filtration Rate Caucasian were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported. Baseline is the last available measurement prior to the first dose of study drug.</population>
          <units>mL/sec/1.73m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.343" spread="0.1955"/>
                    <measurement group_id="O2" value="1.450" spread="0.1265"/>
                    <measurement group_id="O3" value="1.300" spread="0.1503"/>
                    <measurement group_id="O4" value="1.290" spread="0.1273"/>
                    <measurement group_id="O5" value="1.378" spread="0.1482"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for COAGULATION: Prothrombin International Normalized Ratio (INR)</title>
        <description>Blood samples for the assessment of Prothrombin International Normalized Ratio were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for COAGULATION: Prothrombin International Normalized Ratio (INR)</title>
          <description>Blood samples for the assessment of Prothrombin International Normalized Ratio were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>INR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.993" spread="0.0428"/>
                    <measurement group_id="O2" value="1.013" spread="0.0552"/>
                    <measurement group_id="O3" value="1.007" spread="0.0482"/>
                    <measurement group_id="O4" value="0.991" spread="0.0465"/>
                    <measurement group_id="O5" value="0.993" spread="0.0645"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.007" spread="0.0546"/>
                    <measurement group_id="O2" value="-0.038" spread="0.0471"/>
                    <measurement group_id="O3" value="0.016" spread="0.0665"/>
                    <measurement group_id="O4" value="0.013" spread="0.0359"/>
                    <measurement group_id="O5" value="0.057" spread="0.2311"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline at Day 14 for COAGULATION: Prothrombin Time and Activated Partial Thromboplastin Time</title>
        <description>Blood samples for the assessment of Prothrombin Time and Activated Partial Thromboplastin Time were collected upon participants admission to the unit.</description>
        <time_frame>Baseline and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline at Day 14 for COAGULATION: Prothrombin Time and Activated Partial Thromboplastin Time</title>
          <description>Blood samples for the assessment of Prothrombin Time and Activated Partial Thromboplastin Time were collected upon participants admission to the unit.</description>
          <population>Participants with available data reported.</population>
          <units>sec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Prothrombin Time )</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.17" spread="1.871"/>
                    <measurement group_id="O2" value="11.05" spread="1.679"/>
                    <measurement group_id="O3" value="11.91" spread="1.871"/>
                    <measurement group_id="O4" value="11.51" spread="1.757"/>
                    <measurement group_id="O5" value="11.47" spread="1.589"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Prothrombin Time)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.15" spread="0.507"/>
                    <measurement group_id="O2" value="-0.32" spread="0.351"/>
                    <measurement group_id="O3" value="0.12" spread="0.503"/>
                    <measurement group_id="O4" value="0.11" spread="0.291"/>
                    <measurement group_id="O5" value="0.55" spread="2.363"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline(Activated Partial Thromboplastin Time)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.91" spread="2.435"/>
                    <measurement group_id="O2" value="27.09" spread="2.495"/>
                    <measurement group_id="O3" value="28.14" spread="2.483"/>
                    <measurement group_id="O4" value="27.50" spread="2.872"/>
                    <measurement group_id="O5" value="27.55" spread="3.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Baseline (Activated Partial Thromboplastin Time)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.82" spread="1.350"/>
                    <measurement group_id="O2" value="-1.80" spread="1.489"/>
                    <measurement group_id="O3" value="-0.81" spread="1.478"/>
                    <measurement group_id="O4" value="-0.87" spread="1.396"/>
                    <measurement group_id="O5" value="0.58" spread="3.196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Heart Rate (HR) - Change From Baseline (Day -1) at Day 14</title>
        <description>Heart rate was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made.Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
        <time_frame>Baseline (day -1) and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate (HR) - Change From Baseline (Day -1) at Day 14</title>
          <description>Heart rate was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made.Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
          <population>Participants with available data reported.</population>
          <units>beats/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day -1(Predose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.7" spread="9.50"/>
                    <measurement group_id="O2" value="61.6" spread="6.43"/>
                    <measurement group_id="O3" value="65.3" spread="8.43"/>
                    <measurement group_id="O4" value="64.5" spread="5.85"/>
                    <measurement group_id="O5" value="65.0" spread="7.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (0.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.5" spread="9.54"/>
                    <measurement group_id="O2" value="64.5" spread="8.76"/>
                    <measurement group_id="O3" value="66.7" spread="10.56"/>
                    <measurement group_id="O4" value="66.1" spread="9.13"/>
                    <measurement group_id="O5" value="68.7" spread="9.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.8" spread="9.27"/>
                    <measurement group_id="O2" value="66.8" spread="9.58"/>
                    <measurement group_id="O3" value="66.2" spread="9.31"/>
                    <measurement group_id="O4" value="67.6" spread="5.69"/>
                    <measurement group_id="O5" value="67.2" spread="7.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.9" spread="9.26"/>
                    <measurement group_id="O2" value="67.3" spread="7.24"/>
                    <measurement group_id="O3" value="66.5" spread="9.09"/>
                    <measurement group_id="O4" value="67.3" spread="5.38"/>
                    <measurement group_id="O5" value="67.5" spread="7.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.2" spread="10.95"/>
                    <measurement group_id="O2" value="67.3" spread="7.81"/>
                    <measurement group_id="O3" value="65.9" spread="9.96"/>
                    <measurement group_id="O4" value="65.2" spread="4.38"/>
                    <measurement group_id="O5" value="66.3" spread="8.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.7" spread="9.02"/>
                    <measurement group_id="O2" value="69.4" spread="8.86"/>
                    <measurement group_id="O3" value="64.6" spread="10.11"/>
                    <measurement group_id="O4" value="65.1" spread="4.19"/>
                    <measurement group_id="O5" value="68.2" spread="10.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (3 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.4" spread="9.06"/>
                    <measurement group_id="O2" value="64.3" spread="4.91"/>
                    <measurement group_id="O3" value="65.6" spread="7.89"/>
                    <measurement group_id="O4" value="67.9" spread="5.79"/>
                    <measurement group_id="O5" value="68.8" spread="7.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (4 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.0" spread="10.50"/>
                    <measurement group_id="O2" value="62.8" spread="6.70"/>
                    <measurement group_id="O3" value="64.3" spread="6.20"/>
                    <measurement group_id="O4" value="63.9" spread="5.54"/>
                    <measurement group_id="O5" value="67.5" spread="8.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (8 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.9" spread="10.38"/>
                    <measurement group_id="O2" value="64.4" spread="5.95"/>
                    <measurement group_id="O3" value="70.2" spread="10.68"/>
                    <measurement group_id="O4" value="66.9" spread="7.17"/>
                    <measurement group_id="O5" value="70.2" spread="8.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (12 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.0" spread="9.63"/>
                    <measurement group_id="O2" value="68.7" spread="8.96"/>
                    <measurement group_id="O3" value="73.6" spread="7.43"/>
                    <measurement group_id="O4" value="70.7" spread="7.81"/>
                    <measurement group_id="O5" value="71.6" spread="8.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (Pre dose) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="6.87"/>
                    <measurement group_id="O2" value="-0.3" spread="4.08"/>
                    <measurement group_id="O3" value="0.8" spread="6.14"/>
                    <measurement group_id="O4" value="-2.1" spread="6.96"/>
                    <measurement group_id="O5" value="-3.8" spread="8.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (0.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="7.58"/>
                    <measurement group_id="O2" value="-5.1" spread="8.48"/>
                    <measurement group_id="O3" value="-0.9" spread="10.10"/>
                    <measurement group_id="O4" value="-4.3" spread="10.24"/>
                    <measurement group_id="O5" value="-9.6" spread="10.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.0" spread="8.66"/>
                    <measurement group_id="O2" value="-6.7" spread="9.65"/>
                    <measurement group_id="O3" value="-0.6" spread="9.18"/>
                    <measurement group_id="O4" value="-7.9" spread="8.35"/>
                    <measurement group_id="O5" value="-7.7" spread="6.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.5" spread="8.13"/>
                    <measurement group_id="O2" value="-7.4" spread="7.24"/>
                    <measurement group_id="O3" value="-1.5" spread="7.10"/>
                    <measurement group_id="O4" value="-7.9" spread="8.07"/>
                    <measurement group_id="O5" value="-7.6" spread="8.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.5" spread="10.98"/>
                    <measurement group_id="O2" value="-7.9" spread="7.98"/>
                    <measurement group_id="O3" value="-2.4" spread="8.54"/>
                    <measurement group_id="O4" value="-4.2" spread="7.90"/>
                    <measurement group_id="O5" value="-7.0" spread="6.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.2" spread="7.16"/>
                    <measurement group_id="O2" value="-10.5" spread="8.60"/>
                    <measurement group_id="O3" value="-0.3" spread="7.05"/>
                    <measurement group_id="O4" value="-4.2" spread="4.95"/>
                    <measurement group_id="O5" value="-7.8" spread="10.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (3 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.9" spread="9.94"/>
                    <measurement group_id="O2" value="-4.6" spread="5.05"/>
                    <measurement group_id="O3" value="-0.4" spread="8.45"/>
                    <measurement group_id="O4" value="-7.5" spread="7.74"/>
                    <measurement group_id="O5" value="-5.7" spread="9.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (4 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.3" spread="8.57"/>
                    <measurement group_id="O2" value="-2.9" spread="4.83"/>
                    <measurement group_id="O3" value="0.2" spread="8.86"/>
                    <measurement group_id="O4" value="-2.0" spread="7.36"/>
                    <measurement group_id="O5" value="-5.8" spread="7.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (8 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.2" spread="6.22"/>
                    <measurement group_id="O2" value="0.5" spread="5.15"/>
                    <measurement group_id="O3" value="6.8" spread="8.99"/>
                    <measurement group_id="O4" value="1.0" spread="6.47"/>
                    <measurement group_id="O5" value="-2.3" spread="9.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (12 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.9" spread="5.70"/>
                    <measurement group_id="O2" value="0.7" spread="5.74"/>
                    <measurement group_id="O3" value="2.3" spread="8.26"/>
                    <measurement group_id="O4" value="0.0" spread="5.49"/>
                    <measurement group_id="O5" value="-3.2" spread="9.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean PR Interval - Change From Baseline (Day -1) at Day 14</title>
        <description>PR Interval was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
        <time_frame>Baseline (day -1) and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean PR Interval - Change From Baseline (Day -1) at Day 14</title>
          <description>PR Interval was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
          <population>Participants with available data reported.</population>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day -1 (Predose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="165.3" spread="22.20"/>
                    <measurement group_id="O2" value="152.6" spread="14.30"/>
                    <measurement group_id="O3" value="165.3" spread="26.10"/>
                    <measurement group_id="O4" value="166.6" spread="26.74"/>
                    <measurement group_id="O5" value="162.6" spread="20.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (0.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="163.3" spread="24.69"/>
                    <measurement group_id="O2" value="155.3" spread="20.19"/>
                    <measurement group_id="O3" value="167.1" spread="26.74"/>
                    <measurement group_id="O4" value="162.1" spread="22.13"/>
                    <measurement group_id="O5" value="162.4" spread="20.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="166.3" spread="23.76"/>
                    <measurement group_id="O2" value="155.7" spread="20.43"/>
                    <measurement group_id="O3" value="166.6" spread="25.79"/>
                    <measurement group_id="O4" value="166.5" spread="24.32"/>
                    <measurement group_id="O5" value="162.1" spread="19.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="167.6" spread="22.91"/>
                    <measurement group_id="O2" value="158.9" spread="17.73"/>
                    <measurement group_id="O3" value="165.9" spread="21.47"/>
                    <measurement group_id="O4" value="164.9" spread="26.07"/>
                    <measurement group_id="O5" value="162.4" spread="17.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="166.9" spread="25.01"/>
                    <measurement group_id="O2" value="156.0" spread="18.95"/>
                    <measurement group_id="O3" value="167.1" spread="22.27"/>
                    <measurement group_id="O4" value="164.9" spread="25.23"/>
                    <measurement group_id="O5" value="162.9" spread="21.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="14"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168.7" spread="26.32"/>
                    <measurement group_id="O2" value="155.3" spread="18.32"/>
                    <measurement group_id="O3" value="165.8" spread="26.24"/>
                    <measurement group_id="O4" value="165.2" spread="26.51"/>
                    <measurement group_id="O5" value="160.4" spread="21.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (3 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168.0" spread="25.66"/>
                    <measurement group_id="O2" value="153.7" spread="17.61"/>
                    <measurement group_id="O3" value="170.1" spread="31.39"/>
                    <measurement group_id="O4" value="161.8" spread="23.66"/>
                    <measurement group_id="O5" value="160.1" spread="20.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (4 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="165.6" spread="24.06"/>
                    <measurement group_id="O2" value="155.4" spread="17.27"/>
                    <measurement group_id="O3" value="165.1" spread="20.73"/>
                    <measurement group_id="O4" value="163.6" spread="26.48"/>
                    <measurement group_id="O5" value="161.6" spread="16.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (8 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="162.1" spread="23.67"/>
                    <measurement group_id="O2" value="152.5" spread="17.45"/>
                    <measurement group_id="O3" value="161.7" spread="22.93"/>
                    <measurement group_id="O4" value="163.5" spread="25.00"/>
                    <measurement group_id="O5" value="156.4" spread="16.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (12 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="165.7" spread="26.90"/>
                    <measurement group_id="O2" value="157.7" spread="17.41"/>
                    <measurement group_id="O3" value="158.5" spread="19.56"/>
                    <measurement group_id="O4" value="159.0" spread="21.78"/>
                    <measurement group_id="O5" value="156.5" spread="17.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (Pre dose) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="13"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="12.32"/>
                    <measurement group_id="O2" value="1.7" spread="6.41"/>
                    <measurement group_id="O3" value="-1.8" spread="10.85"/>
                    <measurement group_id="O4" value="-0.3" spread="9.42"/>
                    <measurement group_id="O5" value="0.9" spread="12.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (0.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" spread="20.00"/>
                    <measurement group_id="O2" value="0.4" spread="6.90"/>
                    <measurement group_id="O3" value="0.9" spread="14.64"/>
                    <measurement group_id="O4" value="4.6" spread="12.49"/>
                    <measurement group_id="O5" value="-0.8" spread="13.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" spread="15.88"/>
                    <measurement group_id="O2" value="2.8" spread="9.03"/>
                    <measurement group_id="O3" value="-1.0" spread="14.15"/>
                    <measurement group_id="O4" value="2.7" spread="19.24"/>
                    <measurement group_id="O5" value="1.7" spread="13.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="12.86"/>
                    <measurement group_id="O2" value="-2.8" spread="9.59"/>
                    <measurement group_id="O3" value="3.9" spread="17.63"/>
                    <measurement group_id="O4" value="-0.5" spread="11.47"/>
                    <measurement group_id="O5" value="1.8" spread="17.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="12.56"/>
                    <measurement group_id="O2" value="0.6" spread="8.85"/>
                    <measurement group_id="O3" value="-0.9" spread="17.72"/>
                    <measurement group_id="O4" value="0.9" spread="11.82"/>
                    <measurement group_id="O5" value="4.2" spread="14.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="9.34"/>
                    <measurement group_id="O2" value="2.6" spread="13.33"/>
                    <measurement group_id="O3" value="0.0" spread="11.96"/>
                    <measurement group_id="O4" value="1.8" spread="12.11"/>
                    <measurement group_id="O5" value="8.3" spread="15.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (3 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" spread="11.09"/>
                    <measurement group_id="O2" value="5.3" spread="11.40"/>
                    <measurement group_id="O3" value="-3.1" spread="10.83"/>
                    <measurement group_id="O4" value="4.5" spread="15.01"/>
                    <measurement group_id="O5" value="4.9" spread="14.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (4 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="13"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="15.13"/>
                    <measurement group_id="O2" value="1.4" spread="6.48"/>
                    <measurement group_id="O3" value="5.2" spread="20.77"/>
                    <measurement group_id="O4" value="1.8" spread="14.49"/>
                    <measurement group_id="O5" value="2.2" spread="9.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (8 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="8.66"/>
                    <measurement group_id="O2" value="2.9" spread="5.95"/>
                    <measurement group_id="O3" value="0.1" spread="15.03"/>
                    <measurement group_id="O4" value="-3.9" spread="12.21"/>
                    <measurement group_id="O5" value="5.2" spread="6.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (12 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.4" spread="8.83"/>
                    <measurement group_id="O2" value="-3.6" spread="9.17"/>
                    <measurement group_id="O3" value="-0.1" spread="11.07"/>
                    <measurement group_id="O4" value="2.0" spread="9.33"/>
                    <measurement group_id="O5" value="0.9" spread="10.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean QRS Duration - Change From Baseline (Day -1) at Day 14</title>
        <description>QRS Duration was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
        <time_frame>Baseline (day -1) and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean QRS Duration - Change From Baseline (Day -1) at Day 14</title>
          <description>QRS Duration was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
          <population>Participants with available data reported.</population>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day -1(Predose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.8" spread="10.82"/>
                    <measurement group_id="O2" value="93.6" spread="8.11"/>
                    <measurement group_id="O3" value="84.7" spread="6.39"/>
                    <measurement group_id="O4" value="89.2" spread="10.99"/>
                    <measurement group_id="O5" value="89.5" spread="11.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (0.5 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.7" spread="10.44"/>
                    <measurement group_id="O2" value="94.5" spread="7.94"/>
                    <measurement group_id="O3" value="87.4" spread="8.44"/>
                    <measurement group_id="O4" value="88.5" spread="10.86"/>
                    <measurement group_id="O5" value="88.9" spread="10.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.7" spread="10.22"/>
                    <measurement group_id="O2" value="93.3" spread="7.17"/>
                    <measurement group_id="O3" value="85.2" spread="7.94"/>
                    <measurement group_id="O4" value="90.3" spread="9.91"/>
                    <measurement group_id="O5" value="91.2" spread="13.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.4" spread="11.77"/>
                    <measurement group_id="O2" value="91.7" spread="8.52"/>
                    <measurement group_id="O3" value="85.0" spread="7.98"/>
                    <measurement group_id="O4" value="89.5" spread="10.20"/>
                    <measurement group_id="O5" value="92.2" spread="11.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.4" spread="11.08"/>
                    <measurement group_id="O2" value="90.5" spread="7.98"/>
                    <measurement group_id="O3" value="84.0" spread="5.83"/>
                    <measurement group_id="O4" value="89.5" spread="11.15"/>
                    <measurement group_id="O5" value="89.0" spread="10.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.6" spread="12.27"/>
                    <measurement group_id="O2" value="91.5" spread="8.94"/>
                    <measurement group_id="O3" value="84.4" spread="8.22"/>
                    <measurement group_id="O4" value="89.0" spread="10.27"/>
                    <measurement group_id="O5" value="87.8" spread="10.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (3 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.4" spread="10.10"/>
                    <measurement group_id="O2" value="92.7" spread="6.94"/>
                    <measurement group_id="O3" value="85.7" spread="9.32"/>
                    <measurement group_id="O4" value="88.6" spread="10.10"/>
                    <measurement group_id="O5" value="87.9" spread="11.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (4 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.2" spread="11.68"/>
                    <measurement group_id="O2" value="92.3" spread="8.26"/>
                    <measurement group_id="O3" value="85.1" spread="9.68"/>
                    <measurement group_id="O4" value="87.7" spread="11.04"/>
                    <measurement group_id="O5" value="88.7" spread="11.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (8 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.4" spread="11.26"/>
                    <measurement group_id="O2" value="90.9" spread="9.16"/>
                    <measurement group_id="O3" value="81.1" spread="4.41"/>
                    <measurement group_id="O4" value="85.4" spread="11.79"/>
                    <measurement group_id="O5" value="85.3" spread="11.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (12 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.6" spread="10.53"/>
                    <measurement group_id="O2" value="92.0" spread="7.93"/>
                    <measurement group_id="O3" value="85.5" spread="9.13"/>
                    <measurement group_id="O4" value="86.3" spread="10.55"/>
                    <measurement group_id="O5" value="88.1" spread="13.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (Pre dose) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7" spread="3.63"/>
                    <measurement group_id="O2" value="0.3" spread="3.89"/>
                    <measurement group_id="O3" value="-0.8" spread="4.56"/>
                    <measurement group_id="O4" value="-0.1" spread="6.71"/>
                    <measurement group_id="O5" value="3.1" spread="7.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (0.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="7.64"/>
                    <measurement group_id="O2" value="-1.2" spread="5.87"/>
                    <measurement group_id="O3" value="-3.1" spread="5.37"/>
                    <measurement group_id="O4" value="0.4" spread="6.53"/>
                    <measurement group_id="O5" value="2.8" spread="5.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="6.66"/>
                    <measurement group_id="O2" value="0.0" spread="3.57"/>
                    <measurement group_id="O3" value="-1.6" spread="7.46"/>
                    <measurement group_id="O4" value="-0.1" spread="8.88"/>
                    <measurement group_id="O5" value="-2.5" spread="10.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.8" spread="6.00"/>
                    <measurement group_id="O2" value="1.5" spread="6.83"/>
                    <measurement group_id="O3" value="-2.0" spread="6.26"/>
                    <measurement group_id="O4" value="3.4" spread="6.74"/>
                    <measurement group_id="O5" value="-1.8" spread="8.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="8.08"/>
                    <measurement group_id="O2" value="3.2" spread="5.87"/>
                    <measurement group_id="O3" value="-0.8" spread="5.25"/>
                    <measurement group_id="O4" value="1.9" spread="8.34"/>
                    <measurement group_id="O5" value="1.0" spread="8.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="7.13"/>
                    <measurement group_id="O2" value="0.9" spread="4.96"/>
                    <measurement group_id="O3" value="0.4" spread="7.02"/>
                    <measurement group_id="O4" value="1.2" spread="5.61"/>
                    <measurement group_id="O5" value="3.4" spread="7.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (3 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="5.41"/>
                    <measurement group_id="O2" value="0.5" spread="4.87"/>
                    <measurement group_id="O3" value="-1.5" spread="6.56"/>
                    <measurement group_id="O4" value="-1.5" spread="7.06"/>
                    <measurement group_id="O5" value="2.6" spread="8.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (4 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="6.27"/>
                    <measurement group_id="O2" value="0.5" spread="4.61"/>
                    <measurement group_id="O3" value="-2.5" spread="6.44"/>
                    <measurement group_id="O4" value="14.8" spread="49.01"/>
                    <measurement group_id="O5" value="1.7" spread="7.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (8 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.3" spread="3.82"/>
                    <measurement group_id="O2" value="1.5" spread="4.63"/>
                    <measurement group_id="O3" value="0.4" spread="3.41"/>
                    <measurement group_id="O4" value="0.9" spread="6.26"/>
                    <measurement group_id="O5" value="2.5" spread="6.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (12 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.7" spread="6.91"/>
                    <measurement group_id="O2" value="0.3" spread="2.85"/>
                    <measurement group_id="O3" value="-3.3" spread="9.28"/>
                    <measurement group_id="O4" value="-0.5" spread="5.49"/>
                    <measurement group_id="O5" value="-0.8" spread="7.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean QT Interval - Change From Baseline (Day -1) at Day 14</title>
        <description>QT Interval was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
        <time_frame>Baseline (day -1) and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean QT Interval - Change From Baseline (Day -1) at Day 14</title>
          <description>QT Interval was measured as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
          <population>Participants with available data reported.</population>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day -1 (Predose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="421.8" spread="31.07"/>
                    <measurement group_id="O2" value="426.4" spread="23.73"/>
                    <measurement group_id="O3" value="412.6" spread="29.12"/>
                    <measurement group_id="O4" value="421.8" spread="22.12"/>
                    <measurement group_id="O5" value="411.3" spread="16.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (0.5 hour</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="412.4" spread="27.58"/>
                    <measurement group_id="O2" value="422.0" spread="24.00"/>
                    <measurement group_id="O3" value="410.1" spread="29.29"/>
                    <measurement group_id="O4" value="417.7" spread="22.13"/>
                    <measurement group_id="O5" value="405.6" spread="22.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="412.6" spread="22.81"/>
                    <measurement group_id="O2" value="414.6" spread="21.41"/>
                    <measurement group_id="O3" value="415.6" spread="29.17"/>
                    <measurement group_id="O4" value="414.8" spread="21.32"/>
                    <measurement group_id="O5" value="406.5" spread="21.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="413.7" spread="23.60"/>
                    <measurement group_id="O2" value="408.4" spread="19.91"/>
                    <measurement group_id="O3" value="408.0" spread="23.71"/>
                    <measurement group_id="O4" value="414.9" spread="21.19"/>
                    <measurement group_id="O5" value="412.3" spread="22.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="407.4" spread="25.64"/>
                    <measurement group_id="O2" value="405.8" spread="19.18"/>
                    <measurement group_id="O3" value="410.7" spread="33.40"/>
                    <measurement group_id="O4" value="413.4" spread="20.20"/>
                    <measurement group_id="O5" value="412.7" spread="22.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="411.3" spread="27.10"/>
                    <measurement group_id="O2" value="403.4" spread="27.70"/>
                    <measurement group_id="O3" value="410.9" spread="32.10"/>
                    <measurement group_id="O4" value="418.9" spread="32.10"/>
                    <measurement group_id="O5" value="412.4" spread="26.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (3 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="407.8" spread="25.47"/>
                    <measurement group_id="O2" value="411.9" spread="22.80"/>
                    <measurement group_id="O3" value="409.9" spread="24.92"/>
                    <measurement group_id="O4" value="410.7" spread="23.04"/>
                    <measurement group_id="O5" value="401.2" spread="23.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (4 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="408.3" spread="32.47"/>
                    <measurement group_id="O2" value="414.9" spread="20.19"/>
                    <measurement group_id="O3" value="411.2" spread="21.83"/>
                    <measurement group_id="O4" value="418.1" spread="19.01"/>
                    <measurement group_id="O5" value="407.8" spread="16.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (8 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="398.9" spread="29.10"/>
                    <measurement group_id="O2" value="410.3" spread="19.54"/>
                    <measurement group_id="O3" value="396.3" spread="26.84"/>
                    <measurement group_id="O4" value="405.7" spread="22.57"/>
                    <measurement group_id="O5" value="398.5" spread="27.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (12 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="389.2" spread="28.40"/>
                    <measurement group_id="O2" value="407.1" spread="22.55"/>
                    <measurement group_id="O3" value="395.5" spread="22.33"/>
                    <measurement group_id="O4" value="402.2" spread="26.39"/>
                    <measurement group_id="O5" value="394.4" spread="28.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (Pre dose) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.8" spread="17.03"/>
                    <measurement group_id="O2" value="0.2" spread="15.11"/>
                    <measurement group_id="O3" value="-9.6" spread="20.16"/>
                    <measurement group_id="O4" value="-2.1" spread="24.54"/>
                    <measurement group_id="O5" value="5.5" spread="21.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (0.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="17.73"/>
                    <measurement group_id="O2" value="8.7" spread="13.13"/>
                    <measurement group_id="O3" value="-2.4" spread="23.90"/>
                    <measurement group_id="O4" value="10.2" spread="25.32"/>
                    <measurement group_id="O5" value="20.8" spread="24.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="18.73"/>
                    <measurement group_id="O2" value="17.8" spread="15.93"/>
                    <measurement group_id="O3" value="-7.9" spread="28.71"/>
                    <measurement group_id="O4" value="16.3" spread="20.43"/>
                    <measurement group_id="O5" value="17.8" spread="22.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.7" spread="22.95"/>
                    <measurement group_id="O2" value="24.5" spread="14.95"/>
                    <measurement group_id="O3" value="-0.5" spread="19.09"/>
                    <measurement group_id="O4" value="15.7" spread="21.82"/>
                    <measurement group_id="O5" value="17.5" spread="21.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.2" spread="25.19"/>
                    <measurement group_id="O2" value="25.5" spread="18.13"/>
                    <measurement group_id="O3" value="3.6" spread="25.04"/>
                    <measurement group_id="O4" value="16.3" spread="20.76"/>
                    <measurement group_id="O5" value="16.2" spread="16.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" spread="25.18"/>
                    <measurement group_id="O2" value="28.3" spread="22.66"/>
                    <measurement group_id="O3" value="1.4" spread="24.51"/>
                    <measurement group_id="O4" value="12.9" spread="21.11"/>
                    <measurement group_id="O5" value="14.0" spread="23.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (3 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.2" spread="28.90"/>
                    <measurement group_id="O2" value="17.4" spread="15.42"/>
                    <measurement group_id="O3" value="1.9" spread="18.66"/>
                    <measurement group_id="O4" value="18.3" spread="23.65"/>
                    <measurement group_id="O5" value="17.8" spread="28.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (4 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.6" spread="22.90"/>
                    <measurement group_id="O2" value="13.5" spread="15.04"/>
                    <measurement group_id="O3" value="-2.8" spread="23.91"/>
                    <measurement group_id="O4" value="5.5" spread="23.97"/>
                    <measurement group_id="O5" value="18.3" spread="22.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (8 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="14.71"/>
                    <measurement group_id="O2" value="-1.9" spread="12.65"/>
                    <measurement group_id="O3" value="-14.2" spread="18.23"/>
                    <measurement group_id="O4" value="-3.7" spread="20.76"/>
                    <measurement group_id="O5" value="6.6" spread="27.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (12 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="17.62"/>
                    <measurement group_id="O2" value="-0.8" spread="13.58"/>
                    <measurement group_id="O3" value="-12.9" spread="18.71"/>
                    <measurement group_id="O4" value="-1.8" spread="16.37"/>
                    <measurement group_id="O5" value="7.8" spread="24.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean QTcF Interval (Fridericia's Correction Formula, QTcF) - Change From Baseline (Day -1) at Day 14</title>
        <description>Fridericia-corrected QTcF interval was evaluated as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
        <time_frame>Baseline (day -1) and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean QTcF Interval (Fridericia's Correction Formula, QTcF) - Change From Baseline (Day -1) at Day 14</title>
          <description>Fridericia-corrected QTcF interval was evaluated as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
          <population>Participants with available data reported.</population>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day -1(Predose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="432.7" spread="18.75"/>
                    <measurement group_id="O2" value="429.0" spread="16.87"/>
                    <measurement group_id="O3" value="422.3" spread="14.41"/>
                    <measurement group_id="O4" value="431.1" spread="17.28"/>
                    <measurement group_id="O5" value="421.8" spread="20.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (0.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="429.2" spread="16.14"/>
                    <measurement group_id="O2" value="430.9" spread="18.81"/>
                    <measurement group_id="O3" value="422.3" spread="14.40"/>
                    <measurement group_id="O4" value="430.1" spread="16.21"/>
                    <measurement group_id="O5" value="422.6" spread="15.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="432.2" spread="14.68"/>
                    <measurement group_id="O2" value="428.3" spread="14.85"/>
                    <measurement group_id="O3" value="427.3" spread="16.15"/>
                    <measurement group_id="O4" value="430.9" spread="16.46"/>
                    <measurement group_id="O5" value="420.8" spread="13.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="431.7" spread="18.47"/>
                    <measurement group_id="O2" value="423.4" spread="17.60"/>
                    <measurement group_id="O3" value="420.6" spread="14.81"/>
                    <measurement group_id="O4" value="430.5" spread="15.73"/>
                    <measurement group_id="O5" value="427.6" spread="15.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="427.2" spread="17.33"/>
                    <measurement group_id="O2" value="420.5" spread="13.47"/>
                    <measurement group_id="O3" value="420.9" spread="15.57"/>
                    <measurement group_id="O4" value="424.5" spread="16.55"/>
                    <measurement group_id="O5" value="425.2" spread="15.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="428.7" spread="19.29"/>
                    <measurement group_id="O2" value="422.1" spread="21.46"/>
                    <measurement group_id="O3" value="418.3" spread="17.41"/>
                    <measurement group_id="O4" value="429.9" spread="18.39"/>
                    <measurement group_id="O5" value="428.3" spread="17.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (3 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="426.7" spread="16.64"/>
                    <measurement group_id="O2" value="420.3" spread="18.14"/>
                    <measurement group_id="O3" value="419.9" spread="15.56"/>
                    <measurement group_id="O4" value="427.0" spread="15.46"/>
                    <measurement group_id="O5" value="419.0" spread="17.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (4 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="423.4" spread="19.52"/>
                    <measurement group_id="O2" value="420.3" spread="18.14"/>
                    <measurement group_id="O3" value="419.9" spread="14.74"/>
                    <measurement group_id="O4" value="426.2" spread="13.33"/>
                    <measurement group_id="O5" value="423.2" spread="19.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (8 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="423.8" spread="16.12"/>
                    <measurement group_id="O2" value="419.3" spread="15.99"/>
                    <measurement group_id="O3" value="415.5" spread="17.53"/>
                    <measurement group_id="O4" value="419.7" spread="16.65"/>
                    <measurement group_id="O5" value="418.8" spread="25.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (12 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="421.2" spread="16.25"/>
                    <measurement group_id="O2" value="424.2" spread="13.91"/>
                    <measurement group_id="O3" value="422.1" spread="11.25"/>
                    <measurement group_id="O4" value="423.7" spread="20.16"/>
                    <measurement group_id="O5" value="416.8" spread="20.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (Pre dose) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.6" spread="11.74"/>
                    <measurement group_id="O2" value="0.3" spread="12.75"/>
                    <measurement group_id="O3" value="-7.9" spread="13.31"/>
                    <measurement group_id="O4" value="-6.6" spread="22.83"/>
                    <measurement group_id="O5" value="-3.8" spread="13.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (0.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.0" spread="14.97"/>
                    <measurement group_id="O2" value="-2.9" spread="9.31"/>
                    <measurement group_id="O3" value="-4.4" spread="10.52"/>
                    <measurement group_id="O4" value="1.1" spread="14.51"/>
                    <measurement group_id="O5" value="0.4" spread="12.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.6" spread="11.94"/>
                    <measurement group_id="O2" value="2.7" spread="11.08"/>
                    <measurement group_id="O3" value="-8.4" spread="12.88"/>
                    <measurement group_id="O4" value="-1.2" spread="18.18"/>
                    <measurement group_id="O5" value="1.6" spread="15.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1" spread="13.97"/>
                    <measurement group_id="O2" value="8.3" spread="15.45"/>
                    <measurement group_id="O3" value="-3.8" spread="9.02"/>
                    <measurement group_id="O4" value="-2.1" spread="15.16"/>
                    <measurement group_id="O5" value="0.6" spread="15.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="17.40"/>
                    <measurement group_id="O2" value="8.7" spread="11.48"/>
                    <measurement group_id="O3" value="-0.4" spread="15.25"/>
                    <measurement group_id="O4" value="6.7" spread="10.09"/>
                    <measurement group_id="O5" value="0.8" spread="12.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="20.94"/>
                    <measurement group_id="O2" value="5.9" spread="18.24"/>
                    <measurement group_id="O3" value="2.3" spread="13.84"/>
                    <measurement group_id="O4" value="3.8" spread="16.62"/>
                    <measurement group_id="O5" value="-2.3" spread="12.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (3 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="13.91"/>
                    <measurement group_id="O2" value="7.0" spread="17.29"/>
                    <measurement group_id="O3" value="0.3" spread="7.71"/>
                    <measurement group_id="O4" value="2.2" spread="12.14"/>
                    <measurement group_id="O5" value="5.5" spread="15.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (4 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6" spread="11.77"/>
                    <measurement group_id="O2" value="7.1" spread="14.96"/>
                    <measurement group_id="O3" value="-3.8" spread="11.34"/>
                    <measurement group_id="O4" value="0.1" spread="15.55"/>
                    <measurement group_id="O5" value="6.2" spread="22.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (8 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.0" spread="9.55"/>
                    <measurement group_id="O2" value="-1.1" spread="10.67"/>
                    <measurement group_id="O3" value="-1.3" spread="13.74"/>
                    <measurement group_id="O4" value="-1.8" spread="14.03"/>
                    <measurement group_id="O5" value="2.0" spread="22.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (12 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="14.43"/>
                    <measurement group_id="O2" value="1.3" spread="10.33"/>
                    <measurement group_id="O3" value="-9.4" spread="13.78"/>
                    <measurement group_id="O4" value="-1.3" spread="17.43"/>
                    <measurement group_id="O5" value="2.8" spread="17.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Mean QTcB Interval (Bazett's Correction Formula, QTcB) - Change From Baseline (Day -1) at Day 14</title>
        <description>Bazett-corrected QTcB interval was evaluated as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
        <time_frame>Baseline (day -1) and day 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean QTcB Interval (Bazett's Correction Formula, QTcB) - Change From Baseline (Day -1) at Day 14</title>
          <description>Bazett-corrected QTcB interval was evaluated as part of the 12-lead electrocardiogram. Resting ECG recordings were made. Holter monitors were fitted to participants upon admission in clinic on Day -1 and Day 14.</description>
          <population>Participants with available data reported.</population>
          <units>msec</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day -1 (Predose)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="438.6" spread="18.07"/>
                    <measurement group_id="O2" value="430.7" spread="18.10"/>
                    <measurement group_id="O3" value="427.6" spread="13.14"/>
                    <measurement group_id="O4" value="436.1" spread="17.61"/>
                    <measurement group_id="O5" value="417.3" spread="25.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (0.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="438.1" spread="16.29"/>
                    <measurement group_id="O2" value="435.6" spread="21.78"/>
                    <measurement group_id="O3" value="429.1" spread="19.47"/>
                    <measurement group_id="O4" value="436.5" spread="20.61"/>
                    <measurement group_id="O5" value="431.8" spread="20.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="442.8" spread="17.55"/>
                    <measurement group_id="O2" value="435.3" spread="18.84"/>
                    <measurement group_id="O3" value="433.7" spread="18.90"/>
                    <measurement group_id="O4" value="439.4" spread="16.23"/>
                    <measurement group_id="O5" value="428.8" spread="15.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (1.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="441.3" spread="22.48"/>
                    <measurement group_id="O2" value="431.3" spread="20.62"/>
                    <measurement group_id="O3" value="427.4" spread="18.56"/>
                    <measurement group_id="O4" value="438.5" spread="15.28"/>
                    <measurement group_id="O5" value="436.0" spread="16.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="437.8" spread="21.87"/>
                    <measurement group_id="O2" value="428.3" spread="16.51"/>
                    <measurement group_id="O3" value="426.6" spread="17.12"/>
                    <measurement group_id="O4" value="430.3" spread="16.49"/>
                    <measurement group_id="O5" value="432.1" spread="18.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (2.5 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="438.1" spread="21.09"/>
                    <measurement group_id="O2" value="432.1" spread="22.47"/>
                    <measurement group_id="O3" value="422.7" spread="19.67"/>
                    <measurement group_id="O4" value="435.9" spread="18.04"/>
                    <measurement group_id="O5" value="436.9" spread="21.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (3 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="436.6" spread="18.42"/>
                    <measurement group_id="O2" value="425.7" spread="22.43"/>
                    <measurement group_id="O3" value="426.7" spread="16.74"/>
                    <measurement group_id="O4" value="435.5" spread="13.93"/>
                    <measurement group_id="O5" value="428.4" spread="19.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (4 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="431.6" spread="18.31"/>
                    <measurement group_id="O2" value="423.4" spread="21.21"/>
                    <measurement group_id="O3" value="424.6" spread="15.43"/>
                    <measurement group_id="O4" value="430.3" spread="14.06"/>
                    <measurement group_id="O5" value="431.2" spread="26.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (8 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="437.0" spread="14.34"/>
                    <measurement group_id="O2" value="424.2" spread="17.81"/>
                    <measurement group_id="O3" value="425.9" spread="21.39"/>
                    <measurement group_id="O4" value="427.1" spread="18.11"/>
                    <measurement group_id="O5" value="429.5" spread="27.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day -1 (12 hour)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="15"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="438.3" spread="13.91"/>
                    <measurement group_id="O2" value="433.4" spread="16.01"/>
                    <measurement group_id="O3" value="436.4" spread="9.44"/>
                    <measurement group_id="O4" value="434.9" spread="20.98"/>
                    <measurement group_id="O5" value="428.8" spread="17.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (Pre dose) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.7" spread="14.73"/>
                    <measurement group_id="O2" value="-0.3" spread="13.93"/>
                    <measurement group_id="O3" value="-6.9" spread="14.02"/>
                    <measurement group_id="O4" value="-8.9" spread="25.90"/>
                    <measurement group_id="O5" value="-8.5" spread="17.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (0.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.9" spread="19.59"/>
                    <measurement group_id="O2" value="-8.9" spread="17.34"/>
                    <measurement group_id="O3" value="-5.5" spread="13.67"/>
                    <measurement group_id="O4" value="-3.4" spread="19.47"/>
                    <measurement group_id="O5" value="-10.3" spread="17.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-8.0" spread="16.86"/>
                    <measurement group_id="O2" value="-4.6" spread="19.55"/>
                    <measurement group_id="O3" value="-8.9" spread="13.33"/>
                    <measurement group_id="O4" value="-10.3" spread="23.07"/>
                    <measurement group_id="O5" value="-7.5" spread="16.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (1.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.1" spread="16.42"/>
                    <measurement group_id="O2" value="0.0" spread="21.00"/>
                    <measurement group_id="O3" value="-5.5" spread="10.36"/>
                    <measurement group_id="O4" value="-11.1" spread="18.95"/>
                    <measurement group_id="O5" value="-8.5" spread="19.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.7" spread="24.18"/>
                    <measurement group_id="O2" value="-0.1" spread="15.10"/>
                    <measurement group_id="O3" value="-2.9" spread="19.35"/>
                    <measurement group_id="O4" value="1.9" spread="13.13"/>
                    <measurement group_id="O5" value="-7.5" spread="16.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (2.5 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.4" spread="23.12"/>
                    <measurement group_id="O2" value="-5.7" spread="22.17"/>
                    <measurement group_id="O3" value="2.2" spread="15.76"/>
                    <measurement group_id="O4" value="-1.4" spread="17.37"/>
                    <measurement group_id="O5" value="-10.8" spread="16.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (3 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="13.90"/>
                    <measurement group_id="O2" value="1.9" spread="20.81"/>
                    <measurement group_id="O3" value="-0.4" spread="11.01"/>
                    <measurement group_id="O4" value="-6.3" spread="12.49"/>
                    <measurement group_id="O5" value="-0.7" spread="14.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (4 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.4" spread="13.21"/>
                    <measurement group_id="O2" value="3.3" spread="17.73"/>
                    <measurement group_id="O3" value="-4.2" spread="12.68"/>
                    <measurement group_id="O4" value="-2.2" spread="16.13"/>
                    <measurement group_id="O5" value="-0.1" spread="27.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (8 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.4" spread="12.46"/>
                    <measurement group_id="O2" value="-0.8" spread="13.48"/>
                    <measurement group_id="O3" value="5.5" spread="19.09"/>
                    <measurement group_id="O4" value="-0.9" spread="14.17"/>
                    <measurement group_id="O5" value="-0.2" spread="24.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (12 hour) Change from Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="18"/>
                    <count group_id="O2" value="15"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread="15.11"/>
                    <measurement group_id="O2" value="2.1" spread="13.19"/>
                    <measurement group_id="O3" value="-7.5" spread="16.64"/>
                    <measurement group_id="O4" value="-1.2" spread="20.57"/>
                    <measurement group_id="O5" value="-0.2" spread="18.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Nature and Severity of Adverse Events (AEs) up to Day 21</title>
        <description>An AE was defined as any untoward medical occurrence in a subject or clinical trial subject administered a medicinal product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product.&#xD;
Serious Adverse Event (SAE) is an adverse event that at any dose: Results in death, Is life-threatening (i.e. the subject was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it was more severe), Requires inpatient hospitalization or prolongation of existing hospitalization, Results in persistent or significant disability/incapacity, Is a congenital anomaly/birth defect, Is considered to be an important medical event.</description>
        <time_frame>On or after first drug administration up to end of study (Day 21).</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Nature and Severity of Adverse Events (AEs) up to Day 21</title>
          <description>An AE was defined as any untoward medical occurrence in a subject or clinical trial subject administered a medicinal product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product.&#xD;
Serious Adverse Event (SAE) is an adverse event that at any dose: Results in death, Is life-threatening (i.e. the subject was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it was more severe), Requires inpatient hospitalization or prolongation of existing hospitalization, Results in persistent or significant disability/incapacity, Is a congenital anomaly/birth defect, Is considered to be an important medical event.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="11"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Mild TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="10"/>
                    <measurement group_id="O5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Moderate TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Severe TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any serious TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Causally Related TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="7"/>
                    <measurement group_id="O4" value="5"/>
                    <measurement group_id="O5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Causally Related Serious TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Life Threatening Serious TEAE</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any TEAE of Dehydration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Withdrawals Due to AEs up to Day 21</title>
        <description>An AE was defined as any untoward medical occurrence in a subject or clinical trial subject administered a medicinal product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product.&#xD;
Serious Adverse Event (SAE) is an adverse event that at any dose: Results in death, Is life-threatening (i.e. the subject was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it was more severe), Requires inpatient hospitalization or prolongation of existing hospitalization, Results in persistent or significant disability/incapacity, Is a congenital anomaly/birth defect, Is considered to be an important medical event.</description>
        <time_frame>On or after first drug administration up to end of study (Day 21)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Withdrawals Due to AEs up to Day 21</title>
          <description>An AE was defined as any untoward medical occurrence in a subject or clinical trial subject administered a medicinal product and which did not necessarily have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal product.&#xD;
Serious Adverse Event (SAE) is an adverse event that at any dose: Results in death, Is life-threatening (i.e. the subject was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it was more severe), Requires inpatient hospitalization or prolongation of existing hospitalization, Results in persistent or significant disability/incapacity, Is a congenital anomaly/birth defect, Is considered to be an important medical event.</description>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Any TEAE Leading to Discontinuation of Study Drug</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Any TEAE Leading to Study Discontinuation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Frequency of Hot Flushes From Baseline (Day -1) at Days 7, 14 as Assessed by Skin Conductance</title>
        <description>Sternal skin conductance monitors (the Bahr MonitorTM) and the associated algorithm software were supplied by Simplex Scientific LLC (Middleton, USA).&#xD;
Participants were instructed to push a button on the skin conductance monitor when they sensed a hot flush when fitted with the monitor and then provide details of the hot flush in the continuous hot flush diary. Sternal skin conductance monitors were fitted on Day -1 (24 hours±1 hour prior to the planned study drug administration on Day 1) and remained in place until after the Day 7 24-hour assessments were completed (on Day 8). Refitted around 30 minutes prior to study drug administration on Day 14 and remained in place until after the 24-hour assessments were completed on Day 15.</description>
        <time_frame>Baseline (day -1) and days 7, 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Frequency of Hot Flushes From Baseline (Day -1) at Days 7, 14 as Assessed by Skin Conductance</title>
          <description>Sternal skin conductance monitors (the Bahr MonitorTM) and the associated algorithm software were supplied by Simplex Scientific LLC (Middleton, USA).&#xD;
Participants were instructed to push a button on the skin conductance monitor when they sensed a hot flush when fitted with the monitor and then provide details of the hot flush in the continuous hot flush diary. Sternal skin conductance monitors were fitted on Day -1 (24 hours±1 hour prior to the planned study drug administration on Day 1) and remained in place until after the Day 7 24-hour assessments were completed (on Day 8). Refitted around 30 minutes prior to study drug administration on Day 14 and remained in place until after the 24-hour assessments were completed on Day 15.</description>
          <population>Participants with available data reported.</population>
          <units>Hot flushes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline ( Day -1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="17"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="15"/>
                    <count group_id="O5" value="12"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.486" spread="7.148"/>
                    <measurement group_id="O2" value="8.680" spread="4.720"/>
                    <measurement group_id="O3" value="7.787" spread="6.153"/>
                    <measurement group_id="O4" value="3.200" spread="4.945"/>
                    <measurement group_id="O5" value="5.583" spread="7.242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Day -1 to Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="15"/>
                    <count group_id="O2" value="5"/>
                    <count group_id="O3" value="14"/>
                    <count group_id="O4" value="12"/>
                    <count group_id="O5" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.857" spread="6.794"/>
                    <measurement group_id="O2" value="-3.986" spread="6.487"/>
                    <measurement group_id="O3" value="-3.679" spread="4.670"/>
                    <measurement group_id="O4" value="-2.197" spread="4.6090"/>
                    <measurement group_id="O5" value="0.000" spread="6.2450"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Day -1 to day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="12"/>
                    <count group_id="O3" value="13"/>
                    <count group_id="O4" value="10"/>
                    <count group_id="O5" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.139" spread="8.0619"/>
                    <measurement group_id="O2" value="-2.642" spread="6.0682"/>
                    <measurement group_id="O3" value="-2.913" spread="6.4202"/>
                    <measurement group_id="O4" value="0.600" spread="4.9261"/>
                    <measurement group_id="O5" value="-2.908" spread="7.1204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Week -1) at Weeks 1, 2 in Frequency of Moderate to Severe Hot Flushes as Measured by Twice Daily Paper Diary Throughout Study</title>
        <description>Hot flush frequency and hot flush severity were obtained using the Hot Flush paper Diary. Subjects documented the number of individual hot flushes experienced and rated the severity of each on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3). The diaries were completed based on recall twice daily, in the morning and evening.</description>
        <time_frame>Baseline (week -1) and Week 1 ,Week 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Week -1) at Weeks 1, 2 in Frequency of Moderate to Severe Hot Flushes as Measured by Twice Daily Paper Diary Throughout Study</title>
          <description>Hot flush frequency and hot flush severity were obtained using the Hot Flush paper Diary. Subjects documented the number of individual hot flushes experienced and rated the severity of each on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3). The diaries were completed based on recall twice daily, in the morning and evening.</description>
          <units>Hot flushes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week -1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.44" spread="3.866"/>
                    <measurement group_id="O2" value="12.70" spread="3.385"/>
                    <measurement group_id="O3" value="12.04" spread="3.606"/>
                    <measurement group_id="O4" value="10.22" spread="2.976"/>
                    <measurement group_id="O5" value="9.90" spread="2.107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Week -1 to Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.53" spread="3.645"/>
                    <measurement group_id="O2" value="-1.91" spread="4.610"/>
                    <measurement group_id="O3" value="-5.35" spread="5.153"/>
                    <measurement group_id="O4" value="-6.36" spread="3.818"/>
                    <measurement group_id="O5" value="-4.49" spread="2.801"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Week -1 to Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.87" spread="4.179"/>
                    <measurement group_id="O2" value="-3.07" spread="5.647"/>
                    <measurement group_id="O3" value="-7.09" spread="4.915"/>
                    <measurement group_id="O4" value="-8.62" spread="3.749"/>
                    <measurement group_id="O5" value="-6.54" spread="3.453"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Week -1) at Weeks 1, 2 in Average Daily Severity of Hot Flushes as Measured by Twice Daily Paper Diary</title>
        <description>Participants documented the number of individual hot flushes experienced and rated the severity of each on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3). The diaries were completed based on recall twice daily, in the morning and evening.</description>
        <time_frame>Baseline (week -1) and weeks 1, Week 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Week -1) at Weeks 1, 2 in Average Daily Severity of Hot Flushes as Measured by Twice Daily Paper Diary</title>
          <description>Participants documented the number of individual hot flushes experienced and rated the severity of each on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3). The diaries were completed based on recall twice daily, in the morning and evening.</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week -1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.32" spread="0.304"/>
                    <measurement group_id="O2" value="2.31" spread="0.319"/>
                    <measurement group_id="O3" value="2.20" spread="0.267"/>
                    <measurement group_id="O4" value="2.16" spread="0.379"/>
                    <measurement group_id="O5" value="2.19" spread="0.304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Week -1 to Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.30" spread="0.358"/>
                    <measurement group_id="O2" value="-0.21" spread="0.276"/>
                    <measurement group_id="O3" value="-0.23" spread="0.318"/>
                    <measurement group_id="O4" value="-0.51" spread="0.542"/>
                    <measurement group_id="O5" value="-0.34" spread="0.533"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Week -1 to Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.34" spread="0.383"/>
                    <measurement group_id="O2" value="-0.23" spread="0.242"/>
                    <measurement group_id="O3" value="-0.36" spread="0.359"/>
                    <measurement group_id="O4" value="-0.88" spread="0.656"/>
                    <measurement group_id="O5" value="-0.42" spread="0.757"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.4641</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>0.09</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.127</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.12</ci_lower_limit>
            <ci_upper_limit>0.30</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.9894</p_value>
            <method>LS means difference</method>
            <param_type>Linear mixed-effects model</param_type>
            <param_value>0.00</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.128</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.21</ci_lower_limit>
            <ci_upper_limit>0.21</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0199</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-0.31</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.129</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.52</ci_lower_limit>
            <ci_upper_limit>-0.09</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.3907</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-0.12</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.133</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.34</ci_lower_limit>
            <ci_upper_limit>0.11</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.5393</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>0.10</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.166</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.17</ci_lower_limit>
            <ci_upper_limit>0.38</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.7931</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-0.04</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.169</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.33</ci_lower_limit>
            <ci_upper_limit>0.24</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0004</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-0.63</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.169</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.92</ci_lower_limit>
            <ci_upper_limit>-0.35</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.3739</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-0.16</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.175</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.45</ci_lower_limit>
            <ci_upper_limit>0.13</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Week -1) at Weeks 1, 2 in Average Daily Hot Flushes Severity Score as Measured by Twice Daily Paper Diary.</title>
        <description>The hot flushes severity score was a composite of the frequency and severity of hot flushes, and was calculated as follows: number of mild hot flushes recorded on Day Y + number of moderate hot flushes recorded on Day Y × 2 + number of severe hot flushes recorded on Day Y × 3. Higher scores mean more severe hot flushes.</description>
        <time_frame>Baseline (week -1) and week 1 , 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Week -1) at Weeks 1, 2 in Average Daily Hot Flushes Severity Score as Measured by Twice Daily Paper Diary.</title>
          <description>The hot flushes severity score was a composite of the frequency and severity of hot flushes, and was calculated as follows: number of mild hot flushes recorded on Day Y + number of moderate hot flushes recorded on Day Y × 2 + number of severe hot flushes recorded on Day Y × 3. Higher scores mean more severe hot flushes.</description>
          <units>Scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week -1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.06" spread="11.631"/>
                    <measurement group_id="O2" value="33.74" spread="8.875"/>
                    <measurement group_id="O3" value="32.52" spread="11.203"/>
                    <measurement group_id="O4" value="27.87" spread="7.720"/>
                    <measurement group_id="O5" value="26.75" spread="5.416"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Week -1 to Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.99" spread="9.673"/>
                    <measurement group_id="O2" value="-5.56" spread="10.907"/>
                    <measurement group_id="O3" value="-14.48" spread="14.275"/>
                    <measurement group_id="O4" value="-17.03" spread="9.996"/>
                    <measurement group_id="O5" value="-12.23" spread="7.284"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Week -1 to Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-10.67" spread="10.542"/>
                    <measurement group_id="O2" value="-8.02" spread="13.031"/>
                    <measurement group_id="O3" value="-19.19" spread="14.211"/>
                    <measurement group_id="O4" value="-22.82" spread="9.505"/>
                    <measurement group_id="O5" value="-17.55" spread="8.953"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0900</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>5.29</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.077</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.16</ci_lower_limit>
            <ci_upper_limit>10.42</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.1487</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-4.46</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.053</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.55</ci_lower_limit>
            <ci_upper_limit>0.63</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0012</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-10.18</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.015</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-15.20</ci_lower_limit>
            <ci_upper_limit>-5.15</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0548</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-6.14</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.142</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-11.37</ci_lower_limit>
            <ci_upper_limit>-0.90</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0522</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>6.59</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.337</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.03</ci_lower_limit>
            <ci_upper_limit>12.15</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.1326</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-5.07</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.329</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10.61</ci_lower_limit>
            <ci_upper_limit>0.48</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0004</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-12.28</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.270</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-17.73</ci_lower_limit>
            <ci_upper_limit>-6.83</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0253</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-7.79</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>3.408</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-13.47</ci_lower_limit>
            <ci_upper_limit>-2.11</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Frequency From Baseline (Day -1), at Days 7, 14 of Hot Flushes as Measured by Continuous Day Time Diary.</title>
        <description>Subjects recorded each hot flush and its severity on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3) in the hot flush paper diary as they occurred during the day and night.</description>
        <time_frame>Baseline(day -1) and Day 7, 14</time_frame>
        <population>Participants with available data reported.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Frequency From Baseline (Day -1), at Days 7, 14 of Hot Flushes as Measured by Continuous Day Time Diary.</title>
          <description>Subjects recorded each hot flush and its severity on a scale of 1 to 3 (mild = 1, moderate = 2, severe = 3) in the hot flush paper diary as they occurred during the day and night.</description>
          <population>Participants with available data reported.</population>
          <units>Hot flushes</units>
          <param>Least Squares Mean</param>
          <dispersion>90% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 7 Change from Day -1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.8" lower_limit="-4.5" upper_limit="-1.0"/>
                    <measurement group_id="O2" value="-1.4" lower_limit="-3.4" upper_limit="0.6"/>
                    <measurement group_id="O3" value="-5.1" lower_limit="-7.0" upper_limit="-3.2"/>
                    <measurement group_id="O4" value="-8.3" lower_limit="-10.2" upper_limit="-6.4"/>
                    <measurement group_id="O5" value="-5.8" lower_limit="-7.9" upper_limit="-3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 Change from Day -1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.6" lower_limit="-4.9" upper_limit="-2.2"/>
                    <measurement group_id="O2" value="-2.3" lower_limit="-3.8" upper_limit="-0.8"/>
                    <measurement group_id="O3" value="-6.0" lower_limit="-7.5" upper_limit="-4.5"/>
                    <measurement group_id="O4" value="-8.6" lower_limit="-10.0" upper_limit="-7.1"/>
                    <measurement group_id="O5" value="-7.0" lower_limit="-8.6" upper_limit="-5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.3796</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>1.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.58</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.2</ci_lower_limit>
            <ci_upper_limit>4.0</ci_upper_limit>
            <estimate_desc>Day 7 Change from Day -1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.1413</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-2.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.55</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>- 4.9</ci_lower_limit>
            <ci_upper_limit>0.3</ci_upper_limit>
            <estimate_desc>Day 7 Change from Day -1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0007</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-5.5</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.55</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-8.1</ci_lower_limit>
            <ci_upper_limit>-2.9</ci_upper_limit>
            <estimate_desc>Day 7 Change from Day -1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0624</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-3.1</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.62</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.8</ci_lower_limit>
            <ci_upper_limit>-0.4</ci_upper_limit>
            <estimate_desc>Day 7 Change from Day -1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.2930</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>1.3</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.21</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.7</ci_lower_limit>
            <ci_upper_limit>3.3</ci_upper_limit>
            <estimate_desc>Day 14 Change from Day -1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0512</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-2.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.21</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.4</ci_lower_limit>
            <ci_upper_limit>-0.4</ci_upper_limit>
            <estimate_desc>Day 14 Change from Day -1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-5.0</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.20</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-7.0</ci_lower_limit>
            <ci_upper_limit>-3.0</ci_upper_limit>
            <estimate_desc>Day 14 Change from Day -1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0080</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-3.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.25</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.5</ci_lower_limit>
            <ci_upper_limit>-1.3</ci_upper_limit>
            <estimate_desc>Day 14 Change from Day -1</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Week -1) at Weeks 1, 2 in Night-time Awakenings (NTA) Secondary to Hot Flushes as Measured by Paper Diary</title>
        <description>The number of NTAs secondary to hot flushes was the sum of the number of moderate and severe night-time hot flushes recorded the following morning (twice-daily hot flush diary) or recorded contemporaneously on the continuous diary.</description>
        <time_frame>Baseline (week-1) and weeks 1 , 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Week -1) at Weeks 1, 2 in Night-time Awakenings (NTA) Secondary to Hot Flushes as Measured by Paper Diary</title>
          <description>The number of NTAs secondary to hot flushes was the sum of the number of moderate and severe night-time hot flushes recorded the following morning (twice-daily hot flush diary) or recorded contemporaneously on the continuous diary.</description>
          <units>Night-time Awakenings</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (Week -1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.51" spread="2.282"/>
                    <measurement group_id="O2" value="5.61" spread="1.785"/>
                    <measurement group_id="O3" value="5.41" spread="2.337"/>
                    <measurement group_id="O4" value="4.74" spread="2.111"/>
                    <measurement group_id="O5" value="4.76" spread="1.443"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Week -1 to Week 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.77" spread="2.066"/>
                    <measurement group_id="O2" value="-0.80" spread="2.448"/>
                    <measurement group_id="O3" value="-2.52" spread="2.604"/>
                    <measurement group_id="O4" value="-2.75" spread="2.335"/>
                    <measurement group_id="O5" value="-2.07" spread="1.833"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Week -1 to Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.44" spread="2.128"/>
                    <measurement group_id="O2" value="-1.12" spread="2.665"/>
                    <measurement group_id="O3" value="-3.00" spread="2.751"/>
                    <measurement group_id="O4" value="-3.83" spread="2.008"/>
                    <measurement group_id="O5" value="-3.02" spread="2.117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.1482</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>0.84</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.574</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>- 0. 12</ci_lower_limit>
            <ci_upper_limit>1.80</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0734</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-1.04</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.571</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.99</ci_lower_limit>
            <ci_upper_limit>-0.09</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0022</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-1.80</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.565</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.74</ci_lower_limit>
            <ci_upper_limit>-0.86</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0660</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-1.10</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.589</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.08</ci_lower_limit>
            <ci_upper_limit>-0.12</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0593</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>1.18</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.613</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.15</ci_lower_limit>
            <ci_upper_limit>2.20</ci_upper_limit>
            <other_analysis_desc>Change from Week -1 to Week 2</other_analysis_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.1354</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-0.93</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.614</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.95</ci_lower_limit>
            <ci_upper_limit>0.10</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0005</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-2.20</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.603</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.21</ci_lower_limit>
            <ci_upper_limit>-1.20</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive Analysis</non_inferiority_desc>
            <p_value>0.0309</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-1.38</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.628</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.43</ci_lower_limit>
            <ci_upper_limit>-0.34</ci_upper_limit>
            <estimate_desc>Change from Week -1 to Week 2</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline (Day-1) to Day 1 and Day 7 in Luteinizing Hormone (AUC0-8)</title>
        <description>Change in Luteinizing Hormone(LH) AUC from time zero to 8 hours. Pre-dose samples for LH were taken within 30 minutes prior to dose administration.</description>
        <time_frame>baseline (day-1) to day 1 and day 7, pre-dose and post-dose (0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 5.0, 6.0, 8.0, 12.0 and 24.0 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebo</title>
            <description>Placebo to match BAY3427080 capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
          </group>
          <group group_id="O2">
            <title>50 mg BAY3427080</title>
            <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O3">
            <title>100 mg BAY3427080</title>
            <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
          <group group_id="O4">
            <title>150 mg BAY3427080</title>
            <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
          </group>
          <group group_id="O5">
            <title>300 mg BAY3427080</title>
            <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline (Day-1) to Day 1 and Day 7 in Luteinizing Hormone (AUC0-8)</title>
          <description>Change in Luteinizing Hormone(LH) AUC from time zero to 8 hours. Pre-dose samples for LH were taken within 30 minutes prior to dose administration.</description>
          <units>h*U/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="15"/>
                <count group_id="O3" value="15"/>
                <count group_id="O4" value="15"/>
                <count group_id="O5" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day -1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="295.4" spread="82.64"/>
                    <measurement group_id="O2" value="295.5" spread="85.22"/>
                    <measurement group_id="O3" value="290.8" spread="85.83"/>
                    <measurement group_id="O4" value="309.5" spread="104.38"/>
                    <measurement group_id="O5" value="261.1" spread="65.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Day -1 to Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.4" spread="31.33"/>
                    <measurement group_id="O2" value="4.7" spread="35.80"/>
                    <measurement group_id="O3" value="-10.0" spread="21.90"/>
                    <measurement group_id="O4" value="-31.1" spread="38.28"/>
                    <measurement group_id="O5" value="-24.6" spread="32.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Day -1 to Day 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.4" spread="57.46"/>
                    <measurement group_id="O2" value="22.9" spread="37.07"/>
                    <measurement group_id="O3" value="10.2" spread="20.49"/>
                    <measurement group_id="O4" value="-12.1" spread="47.30"/>
                    <measurement group_id="O5" value="-4.4" spread="33.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive analysis</non_inferiority_desc>
            <p_value>0.3768</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-9.7</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>10.88</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-27.8</ci_lower_limit>
            <ci_upper_limit>8.5</ci_upper_limit>
            <estimate_desc>Change from Day -1 to Day 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive analysis</non_inferiority_desc>
            <p_value>0.0248</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-25.0</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>10.89</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-43.1</ci_lower_limit>
            <ci_upper_limit>-6.8</ci_upper_limit>
            <estimate_desc>Change from Day -1 to Day 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive analysis</non_inferiority_desc>
            <p_value>0.0001</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-43.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>10.90</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-62.1</ci_lower_limit>
            <ci_upper_limit>-25.8</ci_upper_limit>
            <estimate_desc>Change from Day -1 to Day 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive analysis</non_inferiority_desc>
            <p_value>0.0004</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-42.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>11.43</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-61.9</ci_lower_limit>
            <ci_upper_limit>-23.8</ci_upper_limit>
            <estimate_desc>Change from Day -1 to Day 1</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive analysis</non_inferiority_desc>
            <p_value>0.4819</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>10.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>14.76</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-14.2</ci_lower_limit>
            <ci_upper_limit>35.1</ci_upper_limit>
            <estimate_desc>Change from Day -1 to Day 7</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive analysis</non_inferiority_desc>
            <p_value>0.8694</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-2.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>14.77</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-27.1</ci_lower_limit>
            <ci_upper_limit>22.2</ci_upper_limit>
            <estimate_desc>Change from Day -1 to Day 7</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive analysis</non_inferiority_desc>
            <p_value>0.1105</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-23.9</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>14.79</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-48.6</ci_lower_limit>
            <ci_upper_limit>0.7</ci_upper_limit>
            <estimate_desc>Change from Day -1 to Day 7</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O5</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>Descriptive analysis</non_inferiority_desc>
            <p_value>0.2390</p_value>
            <method>Linear mixed-effects model</method>
            <param_type>LS means difference</param_type>
            <param_value>-18.4</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>15.50</dispersion_value>
            <ci_percent>90</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-44.2</ci_lower_limit>
            <ci_upper_limit>7.4</ci_upper_limit>
            <estimate_desc>Change from Day -1 to Day 7</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events data were collected on or after first drug administration up to end of study (Day 21).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Placebo Comparator</title>
          <description>Placebo to match BAY3427080 (NT-814) capsules administered orally, daily, for 14 days. Number of placebo capsules to match active dose.</description>
        </group>
        <group group_id="E2">
          <title>50 mg BAY3427080</title>
          <description>50mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
        <group group_id="E3">
          <title>100 mg BAY3427080</title>
          <description>100 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
        <group group_id="E4">
          <title>150 mg BAY3427080</title>
          <description>150 mg of BAY3427080 to be administered as oral capsules, daily, for 14 days</description>
        </group>
        <group group_id="E5">
          <title>300 mg BAY3427080</title>
          <description>300 mg BAY3427080 to be administered as oral capsules, daily, for 14 days.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (20.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="18"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="15"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="15"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="15"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Frequent bowel movements</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Catheter site related reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Medical device site erythema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Medical device site irritation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Medical device site pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E5" events="6" subjects_affected="6" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E5" events="11" subjects_affected="9" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Nightmare</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast tenderness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="18"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="15"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="15"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI is required to postpone communication of results until a joint, multicenter publication of the multicenter study has occurred, or the sponsor confirms that no joint publication will be prepared, or 18 months since completion of the data analysis have passed.&#xD;
The sponsor can review planned publications for up to 60 days and request reasonable amendments. The review period can be extended by up to 6 months in case a patent application is planned.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Therapeutic Area Head</name_or_title>
      <organization>Bayer</organization>
      <phone>(+) 1-888-8422937</phone>
      <email>clinical-trials-contact@bayer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

